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Impacts Of Intracellular Localizations Of Full-Length And Defective Viral 
Genomes On Paramyxovirus Particle Production 
Abstract 
Paramyxoviruses are negative-sense single-stranded RNA viruses that comprise many important human 
and animal pathogens. During viral replication, paramyxoviruses produce defective viral genomes (DVGs), 
truncated genomic products that are unable to replicate in the absence of standard virus. DVGs influence 
the outcomes of infection through interference with standard viral replication and by inducing antiviral 
immunity. Using the model paramyxovirus, Sendai virus (SeV), we found that full-length (FL) and DVG viral 
RNA (vRNA) accumulated heterogeneously in cells during infection, with some cells accumulating 
predominantly full-length genomes (FL-high) and some accumulating predominantly DVGs (DVG-high). 
Interestingly, in FL-high cells genomes accumulated in a perinuclear region while viral genomes in DVG-
high cells remained diffusely distributed throughout the cytoplasm. We sought to address the 
mechanisms and consequences of the differential intracellular distributions of viral RNA in the presence 
of DVGs. We found that vRNA in FL-high cells interacts with the host GTPase Rab11a and uses the 
recycling endosome system for particle production, while viral RNA in DVG-high cells does not interact 
with the host cell in this way. Consequently, FL-high cells produce both standard virions and defective 
particles, while DVG-high cells do not produce virions. We next addressed the determinants of this 
distinct intracellular localization. We reasoned that DVG-high cells, which robustly replicate vRNA but do 
not progress to virion assembly, fail to accumulate the viral proteins required for interaction between 
vRNA and Rab11a. We found that neither SeV matrix nor nucleoproteins are sufficient to drive this 
interaction. We identified the viral polymerase protein L and the accessory protein C as differentiating 
factors in cells that engage with Rab11a, and found C proteins to be the most enriched proteins in Rab11a 
immunoprecipitation followed by mass spectrometry. These data suggest that the polymerase complex 
proteins L and its cofactor C are critical in regulating initial steps in SeV assembly. Overall, this work 
investigated the intracellular distributions of viral genomes in the presence of DVGs to understand the 
impact of DVGs on the dynamics of full length and defective particle production, as well as to gain 
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IMPACTS OF INTRACELLULAR LOCALIZATIONS OF FULL-LENGTH AND 
DEFECTIVE VIRAL GENOMES ON PARAMYXOVIRUS PARTICLE PRODUCTION 
Emmanuelle Genoyer 
Carolina B. López 
 Paramyxoviruses are negative-sense single-stranded RNA viruses that comprise 
many important human and animal pathogens. During viral replication, paramyxoviruses 
produce defective viral genomes (DVGs), truncated genomic products that are unable to 
replicate in the absence of standard virus. DVGs influence the outcomes of infection 
through interference with standard viral replication and by inducing antiviral immunity. 
Using the model paramyxovirus, Sendai virus (SeV), we found that full-length (FL) and 
DVG viral RNA (vRNA) accumulated heterogeneously in cells during infection, with 
some cells accumulating predominantly full-length genomes (FL-high) and some 
accumulating predominantly DVGs (DVG-high). Interestingly, in FL-high cells genomes 
accumulated in a perinuclear region while viral genomes in DVG-high cells remained 
diffusely distributed throughout the cytoplasm. We sought to address the mechanisms 
and consequences of the differential intracellular distributions of viral RNA in the 
presence of DVGs. We found that vRNA in FL-high cells interacts with the host GTPase 
Rab11a and uses the recycling endosome system for particle production, while viral 
RNA in DVG-high cells does not interact with the host cell in this way. Consequently, FL-
high cells produce both standard virions and defective particles, while DVG-high cells do 
not produce virions. We next addressed the determinants of this distinct intracellular 
localization. We reasoned that DVG-high cells, which robustly replicate vRNA but do not 
progress to virion assembly, fail to accumulate the viral proteins required for interaction 
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between vRNA and Rab11a. We found that neither SeV matrix nor nucleoproteins are 
sufficient to drive this interaction. We identified the viral polymerase protein L and the 
accessory protein C as differentiating factors in cells that engage with Rab11a, and 
found C proteins to be the most enriched proteins in Rab11a immunoprecipitation 
followed by mass spectrometry. These data suggest that the polymerase complex 
proteins L and its cofactor C are critical in regulating initial steps in SeV assembly. 
Overall, this work investigated the intracellular distributions of viral genomes in the 
presence of DVGs to understand the impact of DVGs on the dynamics of full length and 
defective particle production, as well as to gain insights into viral proteins required to 
initiate viral assembly.   
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1.1.1 Paramyxoviruses in human and animal disease 
Paramyxoviruses are negative-sense single-stranded RNA viruses that infect a 
wide range of animals causing a broad spectrum of diseases. Paramyxoviruses 
comprise many important human and animal pathogens that have high global burdens of 
morbidity and mortality. Some paramyxoviruses including measles, mumps, Rinderpest, 
and Newcastle Disease Virus are vaccine preventable or have been eradicated (1). 
However, among paramyxoviruses there are a number of human pathogens which 
currently lack vaccines and cause a human health burden. These include the human 
parainfluenza viruses (HPIV), which include the respirovirus genus members HPIV1 and 
HPIV3, and the rubulavirus genus members HPIV2 and HPIV4. These viruses circulate 
in the summer and fall of alternating years and cause disease in young children. HPIV1 
and HPIV2 are the leading cause of croup in young children and HPIV3 is associated 
with bronchiolitis, bronchitis, and pneumonia(2). These infections have also been 
associated with the development or exacerbation of asthma and chronic airway 
disorders(3).  Additionally, a study in 2015 demonstrated that HPIVs were the etiological 
agent of 7% of hospitalized pneumonia cases in U.S. children(4), and a study of children 
across five countries in Africa and Asia recapitulated these data in 2018(5). Importantly, 
there are no direct acting antivirals or prophylactic vaccines for these viruses.  
Additionally, there are a number of zoonotic or epizootic paramyxoviruses which 
have caused small outbreaks in human populations for the past three decades and 
continue to pose a threat as emerging viruses. The viruses in the henipavirus genus, 
Hendra virus and Nipah virus, have caused a number of outbreaks with high case fatality 
rates since the 1990s. Henipaviruses circulate in bats and while little is known about 
these viruses in bats, they are not thought to cause severe disease in their host species. 
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However, spillover to human populations has proved deadly(6). Hendra virus (HeV) can 
cause fatal neurological disease in horses and in humans. HeV first appeared in 
Australia in 1994 and has since caused over 100 equine deaths and 7 human deaths, 
with spillovers being observed at least once a year(6, 7). While there is evidence that the 
virus may be transmitted from horse to human there is little evidence of sustained 
human to human transmission. Additionally, while there is now an efficacious vaccine for 
horses, there is no approved human vaccine(8). Nipah virus (NiV) was first identified in 
1998 in an outbreak in Malaysia and Singapore(9). Since then it has crossed from bats 
to humans a number of times, presumably via consumption of fruits contaminated with 
bat urine or feces(9). Unlike HeV, NiV outbreaks have been partially driven by human to 
human transmission, with some outbreaks recording up to 75% of cases due to human 
to human transmission chains (6). These outbreaks have had high case fatality rates 
with some outbreaks reaching a case fatality rate of nearly 95% and there are no 
approved vaccines or direct acting antivirals(10). A number of other viruses in the 
henipavirus family that currently circulate in bats are being monitored for their potential 
transmission to humans, including Cedar virus. Additionally, other paramyxovirus 
genuses include viruses that circulate in bats, such as the rubulavirus Sosuga virus, and 
Beilong virus which belongs to its own genus, have shown limited transmissions to 
humans and are also monitored for their potential to spark outbreaks in human 
populations(11).  
Finally, while vaccines were developed against measles and mumps in the 
1950s, and by 1971 there was a licensed combination measles, mumps, and Rubella 
vaccine licensed in the United States that shows 93% efficacy against measles and 88% 
efficacy against mumps after two doses(12), challenges with vaccine adherence and 
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distribution have continued to leave people vulnerable to measles virus infection. 
Additionally, waning humoral immunity to the mumps vaccine, even in fully immunized 
populations, has led to periodic outbreaks(13). Further, Newcastle disease virus, also 
known as avian avulavirus 1, which affects poultry and can be economically devastating 
when livestock are infected. While there is an effective vaccine against NDV, not all 
animals are vaccinated and there continue to be periodic outbreaks of this virus. Thus, 
even in the presence of effective vaccines, these diseases continue to cause economic 
and health burdens across the world.  
 With currently circulating paramyxovirus infections in humans that cause a 
significant health burden, as well as potential zoonotic paramyxoviruses that lack 
vaccines or treatments, it is particularly important to continue to study the basic biology 
of these viruses. Understanding how the virus interacts with the host during infection can 
yield various therapeutic targets that are either host or virus directed.   
1.1.2 Paramyxovirus Replication  
1.1.2.1. Viral genes and genomic replication 
Paramyxoviruses are negative-sense single-stranded RNA viruses, which means 
that their genomic RNA must be transcribed to positive-sense mRNA before being 
translated in cells and the virus relies on a positive-sense intermediate antigenome for 
replication (14).  Paramyxoviruses code for six essential genes and a number of 
accessory proteins. The six genes that comprise the essential genes of paramyxoviruses 
in their order on the genome are as follows (Fig 1.1A). 1) The nucleoprotein (NP) is the 
most abundant protein product and coats the viral genome during replication and within 
the virion. It is reported that there is one nucleoprotein for every six nucleotides in the 
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genome and that this interaction is very strong and stable(15, 16). This complex of viral 
RNA coated in nucleoprotein is known as the viral nucleoprotein or vRNP. 2) The 
phosphoprotein (P) is a cofactor for the viral polymerase and is required for viral 
replication and efficient nucleocapsid formation(17, 18). 3) The Matrix protein (M) lines 
the inner membrane of the virion and is important for driving contact between the vRNP 
and the surface proteins(19, 20). 4+5) The surface proteins are Fusion (F) and 
Hemagglutinin (H) proteins (or Glycoprotein (G) or Hemagglutinin/Neuraminidase (HN), 
depending on functionality), and are responsible for cell fusion and cellular attachment 
and activation of fusion respectively(20-22). 6) The polymerase or Large protein (L) is 
the RNA dependent RNA polymerase (RdRP) that catalyzes the addition of nucleotides 
and includes methyltransferase activity for capping nascent mRNA(14, 23). 
Paramyxoviruses also encode a number of accessory proteins from the P gene, the 
number and type of which vary by genus, that primarily function as innate immune 
antagonists(24). 
Paramyxoviruses enter the cell by fusion at the plasma membrane. 
Hemagglutinin proteins bind to cell surface receptors and trigger conformational changes 
to allow the fusion protein to direct fusion between the viral membrane and the cellular 
plasma membrane(25) whereby viral genomic contents are deposited into the host 
cell(26). Upon entry, negative sense viral genomes are coated with nucleoprotein and 
carry with them L and P proteins. The L-P protein complex, or polymerase complex, 
recognizes the leader sequence at the 3’ end of the virus and synthesizes short RNA 
strands before recognizing a gene start signal, which signals for the polymerase to 
create a capped mRNA. The polymerase continues to synthesize mRNA until it reaches 
the gene end sequence, where it will stutter along a polyU track to generate a polyA tail 
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for the mRNA. The polymerase then continues to scan the viral genome until it finds the 
next gene start sequence and begins to make the following mRNA(14). As the 
polymerase continues along the viral genome, it may lose processivity and fall off of the 
template strand. This leads to a gradient of mRNA expression where the first 
synthesized (3’ proximal) mRNAs are in highest abundance and the last synthesized (5’ 
proximal) mRNAs are at the lowest abundance(27) (Fig. 1.1.A). Viral mRNA is then 
translated and post-translationally modified by host cell ribosomes and host proteins. 
After several rounds of transcription and the accumulation of viral proteins, the 
viral RdRP will change from “transcriptase” mode to a “replicase” mode and instead of 
synthesizing mRNA will begin to synthesize viral RNA (vRNA) genomes. It is 
hypothesized that the switch between transcriptase and replicase is governed by 
accumulation of NP proteins, whereby when a sufficient level of NP proteins coat the 
nascent RNA generated from the 3’ end of the leader, the RdRP will bypass gene start 
events to create a vRNA(28, 29). The processive synthesis of vRNA form the negative 
strand genome yields a positive sense anti-genome, which is also completely coated in 
NP. The positive sense anti-genome contains the inverse trailer region which acts as a 
promoter and can be recognized by the RdRP to initiate replication. Importantly, the 
trailer region does not initiate any transcription events, and only replication can occur 
from this promoter. The antigenome is used as a template to generate negative sense 
genomes, which are able to propagate the viral lifecycle(14, 30). It has been reported 
that in Sendai virus, the trailer region is about 40 times stronger a promoter than the 
leader region which drives the synthesis of higher levels of negatives sense genomes 





Figure 1.1 General Replication Strategy of Paramyxoviruses (A) Gene organization of SeV 
(B) Replication strategy of paramyxoviruses (1) Upon entry, the viral polymerase synthesizes 
capped and polyadenelyated mRNA, beginning at the 3’ end of the genome. The polymerase 
progressively loses processivity leading to a gradient of mRNA with high levels of 3’ proximal 
mRNAs and low levels of 5’ proximal mRNAs. (2) After initial transcription of viral mRNA and 
accumulation of viral proteins, the polymerase switches to replication and generates an 
antigenome that is coated with nucleoprotein as it is synthesized (3) Positive-sense anti-genomes 
coated in nucleoproteins are replicated by the polymerase beginning at the 3’trailer to generate 
more negative-sense genomes. 
1.1.2.2 Intracellular sites of replication  
In contrast to positive sense RNA viruses which form membranous vesicles or 
associate with the endoplasmic reticulum, paramyxoviruses replicate within the 
cytoplasm of infected cells. Additionally while the nucleocapsid and matrix proteins of 
some paramyxoviruses have been reported to transit through the nucleus for post 
translational modifications such as ubiquitination(32, 33), their genomes do not have a 
nuclear phase. Viral genomes are replicated freely in the cytoplasm of cells. While 
inclusion body (IB) formation appears to be a hallmark of other negative sense virus 
families, including rhabdoviruses(34), filoviruses(35), and pneumoviruses(36, 37), some 
but not all paramyxoviruses have been reported to form inclusion bodies during 
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replication. For example, formation of inclusion bodies is a hallmark of Canine distemper 
virus (CDV)infection(38). Additionally, while IBs have been described to form during 
infection with parainfluenza virus 5 (PIV5)(39), measles virus(40, 41), and NiV(42), these 
IBs have been characterized as dynamic, forming and diffusing during infection. IBs are 
protein condensates that form in the cytoplasm and are driven by the accumulation of 
viral proteins with intrinsically disordered domains. These IBs are often classified as 
membranelles organelles that form by liquid-liquid condensation(37, 43). IBs are thought 
to concentrate viral RNA and viral proteins within the cytoplasm to increase rates of 
replication and to shield viral RNA from host cell sensors(44). However, not all 
paramyxoviruses replicate using IBs and the factors that dictate the formation of these 
inclusion bodies is not well understood.  
1.1.3 Paramyxovirus Assembly and Virion Components 
 While viral genomes are replicated in the cytoplasm of infected cells, the virus 
buds from the plasma membrane and therefore the genome must be trafficked to the 
plasma membrane for virion assembly(20). Many negative sense RNA viruses have 
developed strategies to target their genome to the plasma membrane by hijacking the 
host recycling endosomal pathway(45). Host recycling endosomes travel along actin and 
microtubules propelled by the small guanine triphosphatase (GTPase) Rab11a. 
Recycling endosomal networks transport cargo in a bidirectional manner, to and from the 
perinuclear endosomal recycling center and the plasma membrane(46). This concerted 
bidirectional movement has been coopted by a number of viruses including 
paramyxoviruses(47-50), orthomyxoviruses(51, 52), pneumoviruses(53), filoviruses(54), 
and hantaviruses(55).  
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The paramyxoviruses Sendai virus(48), measles(50), mumps(49), and human 
parainfluenza 1 virus(47) have been shown to be dependent on Rab11a and  
microtubules for the movement of vRNPs within the cytoplasm and for the production of 
infectious particles (Fig. 1.2). Whereas vRNPs use Rab11a to traffic to the plasma 
membrane, the surface proteins F 
and HN are synthesized in the 
endoplasmic reticulum and 
trafficked to the plasma membrane 
via the secretory pathway (22) and 
are preferentially sorted to lipid 
rafts(56). F and HN are thought to 
be trafficked independently of each 
other and recent work has shown 
that NiV surface proteins are 
stochastically incorporated into 
virions, rather than being 
incorporated at a fixed 
stoichiometric ratio, supporting the 
idea that these proteins reach the 
plasma membrane independently 
of each other.  
The oligomeric matrix protein which forms a matrix along the plasma membrane 
serves to bridge the contacts between the surface proteins and the vRNPs(19).  The 
incorporation of NiV F and G protein into virion occurs by interactions with matrix 
 
Figure 1.2. Schematic of Paramyxovirus Assembly 
Viral ribonucleoprotein complexes are replicated in the 
host cell cytoplasm. After accumulation of viral 
proteins, vRNPs use recycling endosomes to transit to 
the plasma membrane where they interact with matrix, 
Fusion and hemagglutinin/neuraminidase proteins 
distributed on the cell surface.  
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protein(57). Matrix is also thought to direct specificity of vRNP incorporation into virions. 
For example, while NP proteins from closely related SeV and HPIV1 are able to coat the 
others genomes, they are not able to interact with their orthologous matrix protein and 
form viral particles, indicating that NP-matrix contacts are important for producing 
virions(58).  
While the expression of matrix protein alone is sufficient to drive the production of 
virus like particles in cells for most paramyxoviruses, including SeV(59) and HPIV1(60), 
the association between the vRNPs and matrix is thought to enhance budding as vRNPs 
induce curvature of the host membrane to induce scission(61). While many viruses 
including retroviruses, filovirus, and rhabdoviruses use ESCRT proteins to drive 
membrane scission and produce particles, the use of ESCRT by paramyxoviruses is not 
universal(62). Viruses that use ESCRT for particle production include NiV(63), PIV5 (64) 
and mumps(65). These viruses recruit ESCRT proteins via PPXY-like late domains in 
their matrix proteins. However, other paramyxoviruses including measles bud in an 
ESCRT independent manner(66). In addition, other membrane scission proteins 
involved in vesicle formation such as Aip1/Alix have been shown to be recruited by 
matrix and C proteins to enhance particle production in SeV(67, 68), but their 
requirement for particle production remains contested(69). The accessory protein C, 
generated from the P gene mRNA in SeV, HPIV1, MeV, NiV and others, has also been 
implicated to play a role in particle production, either by enhancing the recruitment of 
Aip1/Alix or Tsg101, an ESCRT component, to the plasma membrane(63, 68) or by 
driving vRNP migration to the plasma membrane(70).  
 Though particle production has been long studied and the identification of the 
involvement of Rab11 endosomal pathway has illuminated mechanisms of virus 
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trafficking to the plasma membrane, there are still a number of questions surrounding 
the assembly of paramyxoviruses. First, the viral and host proteins that are critical for 
vRNP interaction with Rab11a are unknown. It is clear that vRNPs interact with Rab11a, 
but, the elements of the vRNP that interact with Rab11a are unknown. In addition, it 
remains to be determined if another viral protein or other host factors are involved in this 
interaction.  Further, the mechanisms of transport of matrix proteins and the involvement 
of C protein in particle production remain contested despite having been studied for a 
long time. Finally, differences amongst paramyxoviruses, particularly in those that 
express different accessory proteins, remains to be explored. The identification of 
specific mechanisms of either virus or host proteins involved in virion assembly could 
provide targets for the development of antivirals for a number of important diseases.  
1.1.4 Sendai Virus 
Sendai virus (SeV), recently renamed murine parainfluenza virus 1, is a member 
of the respirovirus genus of the paramyxovirus family. The SeV genome is approximately 
15kb in length with enveloped virions ranging in size from 110-540nm in diameter, based 
on the amount of viral RNA that has been packaged(71). As a prototypical 
paramyxovirus, SeV expresses the six common genes, as well as a large number of 
accessory proteins from the P gene. These accessory proteins include four C proteins 
(C, C’, Y1, and Y2), which have been described to antagonize the interferon response by 
binding to STAT1 and preventing its nuclear translocation(72), as well as having roles in 
particle production as discussed above(70), and regulating the polarity of genome 
synthesis(73). C proteins are generated from the P mRNA by translation initiations at 
alternate start sites downstream of the primary AUG(74).  V proteins are expressed from 
mRNA generated by the insertion of a G during P mRNA synthesis which creates a 
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frame shift. Therefore V proteins share N terminus amino acid sequences with P but 
have a unique C terminus. The V protein is an innate immune antagonists and functions 
by blocking MDA5 activation to prevent IRF3 activation(75), blocking NLRP3 
inflammasome activation to prevent IL1b secretion(76), and binding to RIG-I/TRIM25 to 
prevent RIGI ubiquitination and subsequent activation(77). These proteins are 
dispensable for replication in vitro but are required for pathogenesis in animal 
models(78, 79).   
SeV infects rodents and causes a respiratory disease, with virus restricted to 
replication in the lung in the presence of tryptase Clara, a specific trypsin secreted by 
Clara (or Club) cells in the lung(80). While the virus has a strong organ specific tropism, 
and primarily replicates in bronchial epithelial cells, type I and type II pneumocytes, and 
alveolar macrophages, there are no entry specific factors that restrict this virus to 
rodents or to respiratory tissues, as SeV enters via binding to sialic acid(81).  In natural 
hosts, SeV causes an acute disease and spreads rapidly amongst outbred and wild 
animals primarily via contact, with peak virus titers occurring 4 to 5 days post 
infection(82). Disease is characterized by roughened coat hair, dyspnea and, weight 
loss(1).  Viral clearance is dependent on CD8+ T cells that are recruited to the lung by 
strong innate immune responses initiated by cell intrinsic immunity(83, 84). Mice will 
clear detectable SeV by day 10 or 11 and develop immunity characterized by a robust 
CD8+ T cell and antibody response. However, SeV can cause long term damage to 
lungs of infected animals(85, 86) and there is long standing evidence that SeV can 




SeV is most closely related to human parainfluenza virus 1, with 69% sequence 
homology at the nucleotide level. In fact, their high degree of similarity leads to cross 
reactivity of neutralizing antibodies both in humans and mice(88). Other respiroviruses 
closely related include HPIV3 and bovine parainfluenza virus. Because SeV can be 
easily studied in its natural host, it provides an excellent model system for studying these 
important human diseases. Additionally, SeV has been a longstanding model for 
paramyxoviruses and for negative sense single stranded RNA viruses as a whole with 
which many fundamental discoveries regarding the replication of RNA viruses have been 
made.  
1.2 Defective Viral Genomes 
DVGs exist across many viral families including DNA viruses, retroviruses, and 
RNA viruses(89-91). Defective viral genomes (DVGs) are viral replication products 
derived from the parental genome that in the absence of coinfection with a standard 
virus are unable to carry out a full replication cycle. DVGs can have small to large 
internal substitutions, deletions, and/or insertions that make the genome unable to 
produce one or more critical proteins while retaining their replication and packaging 
potential. Replication strategies of viruses are diverse, and the species of DVGs 
generated during replication are just as diverse within and across viral families. 
However, DVGs may be produced whenever a virus replicates. 
1.2.1 Types and Generation of defective viral genomes 
Among RNA viruses there are two dominant types of DVGs: deletion DVGs and 
snapback or copy-back DVGs. Both types of DVGs maintain the ability to complete a full 
replication cycle when complemented by a standard virus. 
1.2.1.1 Deletion Defective Viral Genomes 
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Deletion DVGs retain both genomic termini that contain replication promoters but 
lack internal regions of the viral genome (Figure 1.3). Deletions can range from a few 
nucleotides, leading to alterations in or loss of certain  
viral proteins, to large truncations that preserve only the minimum amount of genome 
required to undergo replication by the viral polymerase(93, 94). Deletion DVGs are often 
found in positive-sense RNA viruses, including flaviviruses(95), alphaviruses(96), 
coronaviruses(97), and picornaviruses(98). Deletion DVGs are hypothesized to be 
formed when the viral polymerase begins to copy the template strand but falls off from 
the template at a break point and continues replication at a distal rejoin point on a new 
 
Figure 1.3.  Types of DVGs and their proposed mechanisms of generation. Deletion 
DVGs are generated when the polymerase falls off a template strand at a break region and 
either switches to a new template strand or continues along the same template strand while 
skipping internal regions, rejoining at a deletion rejoin region that may have sequence 
homology to the region immediately following the break point. Copy-back DVGs are generated 
when the polymerase releases the template strand at a break point and rejoins the nascent 
strand at a nonhomologous region, creating a nonhomologous theoretical loop structure 
flanked by complementary ends. Snapback DVGs are formed similarly to copy-back DVGs but 
lack significant nonhomologous regions because the rejoin points are proximal to the break 




template, skipping internal regions of the genome. Identification of small degrees of 
sequence homology at the break and rejoin regions of deletion DVGs led to the 
hypothesis that DVG generation may be driven by homologous recombination(96, 99). 
This hypothesis is supported by evidence that mutations in the viral polymerase that 
enhance recombination lead to more DVG generation in alphaviruses(96). Additionally, 
analysis of poliovirus DVGs indicated that predicted secondary structures in the genome 
encourage copy-choice recombination around sites frequently found in DVGs(100). 
The majority of DVGs described from the negative-sense RNA influenza viruses 
and bunyaviruses are also deletion-type DVGs(101-103). Like in positive-strand RNA 
viruses, sequences in the break and rejoin regions of influenza virus DVGs share 
nucleotide similarities(104, 105). However, unlike in positive-strand viruses, homologous 
recombination events are rare in negative-strand viruses including influenza(106). 
Mutations in the influenza virus polymerase acidic (PA) protein enhance DVG 
generation(107, 108), and it has been hypothesized that tertiary structures of influenza 
viral ribonucleoproteins may underlie the relationship between break and rejoin 
points(105), indicating that DVG generation in these viruses may be driven by different 
mechanisms. 
1.2.1.2 Copy-Back and Snapback Defective Viral Genomes  
The predominant species of DVGs found in negative-sense RNA viruses are 
copy-back and snapback genomes. These DVGs are generated from the 5′ end of the 
viral genome and consist of a theoretical loop with complementary ends(109) (Figure 
1.3). Snapback DVGs, differently from copy-back DVGs, do not contain much of a loop 
and are predominantly complementary with as little as a single noncomplementary 
nucleotide (110). Mechanisms for the generation of this type of DVG are still poorly 
understood. The prevailing model is that during viral replication the polymerase falls off 
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the template strand at a break point, rejoins the nascent strand at a rejoin point, and 
begins to copy back. Unlike minimally complementary regions found in break and rejoin 
points in deletion DVGs, there does not seem to be homology between break and rejoin 
points in copy-back DVGs. Because of the lack of a discernable pattern of copy-back 
DVG generation, it was thought to be a random process driven by an error-prone viral 
polymerase. However, sequence analysis of DVGs from the rhabdovirus vesicular 
stomatitis virus (VSV) found that some sequences may act as signals to the polymerase 
and may be more prone to act as break or rejoin points(111). Additional work from our 
laboratory shows that there are conserved regions in the genome of the pneumovirus 
respiratory syncytial virus (RSV) that act as rejoin points during infection and that a 
specific nucleotide composition is required in these regions for optimal DVG formation 
(112). The molecular mechanisms underlying the use of these specified break and rejoin 
points are the subject of current investigation. 
1.2.1.3 Other Types of Defective Viral Genomes 
While deletion and copy-back DVGs are the most prevalent, a wide range of viral 
genomic products can be classified as DVGs. A recently described type of DVG in 
influenza virus does not contain any deletions; rather, a viral segment is heavily mutated 
in promoter regions and packaging signals so that it interferes with replication of the 
standard virus(113). Other types of DVGs include mosaic or complex DVGs, which 
include viral genomes from different segments of segmented viruses, different viruses 
coinfecting a single host cell, or parts of the host genome(105, 114). 
1.2.2 Defective Particles and Their Defective Viral Genomes  
It is important to make the distinction between DVGs and defective particles 
(DPs) (historically referred to as DIPs) when interpreting literature and considering the 
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effects that defective viruses have during an infection. DVGs are, as described, viral 
genomes lacking regions of the genome that render them replication incompetent in the 
absence of a standard virus. These genomes may be either inside cells or inside viral 
particles. DPs are virions that contain a DVG. DIPs, as historically referred to, 
necessitate the function of interference, as is stated in their name; however, not all DPs 
are necessarily interfering. 
DVGs may be generated de novo within an infected cell by the mechanisms 
discussed above. While specific conditions that facilitate either the generation or the 
accumulation of DVGs are unknown, there is evidence that host factors including host 
species and cell type can influence DVG generation. For example, avian influenza virus 
strains are more likely to generate aberrant replication products when they replicate in 
mammalian hosts and vice versa(115, 116), and West Nile virus (WNV) DVG generation 
and accumulation are affected by the host cell type and mouse strain used to expand the 
virus(117). Additionally, viral factors are implicated in DVG generation. Various 
mutations in the polymerase that alter fidelity can encourage DVG generation(96, 107), 
and different viral accessory proteins are implicated in regulating DVG generation in 
paramyxoviruses and orthomyxoviruses(118-120). Regardless, DVGs are generated  
when infections occur at a high multiplicity of infection(109, 121). DVGs generated de 
novo within an infected cell may impact the rate of standard virus replication and the 
accumulation of viral proteins, and they may have different functional consequences 
within the cell (Fig. 1.4). 
DPs can spread to other cells during infection. To create a DP, a DVG must be 
packaged into a virion, and for some viruses this process requires a specific packaging 
signal. If deletion DVGs fail to retain packaging signals, they will not be transmitted as 
DPs. Examples include deletion DVGs generated during Semliki Forest virus, which  
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helped define critical packaging signals in the viral nonstructural protein nsp2(122), as 
well as clinically isolated DVGs identified in Middle East respiratory syndrome  
coronavirus that contain large deletions between ORF5 and the E gene and, therefore, 
may be unable to be packaged(123). These types of DVGs may affect the cell in which 
they arise de novo but might not be transmitted or amplified in other cells, except 
 
Figure 1.4 Impact of DVGs during infection. DVGs can limit standard viral replication 
through interference in a number of different ways within an infected cell, often with one type of 
interference leading to multiple levels of restriction on the standard virus. (1) DVGs can 
compete with standard virus for viral replication machinery including polymerase and 
nucleoproteins and may be at an advantage to standard virus due to their size or their 
promoters, leading to a decreased ratio of standard virus to DVGs. (2) Increased levels of 
DVGs compared to standard virus can decrease available templates for viral mRNA synthesis 
either because deletion DVGs lack coding regions for certain mRNAs or because copy-back 
and snapback DVGs are unable to code for any mRNA and thereby lead to reduced 
accumulation of viral proteins in the cell. (3) The limited amount of viral proteins can lead 
DVGs to compete with standard virus for surface proteins for assembly, compete with standard 
segments for incorporation into virions in segmented virus, or even induce degradation of 
surface proteins, leading to a decrease in virion production. (4) Increased accumulation of 
DVGs within the cell can trigger pattern recognition receptors to initiate signaling cascades 
leading to the upregulation of interferons and interferon-stimulated genes, which can in turn 
have inhibitory effects on viral replication or particle production. Abbreviations: DVG, defective 
viral genome; ISRE, interferon-sensitive response element; PAMP, pathogen-associated 




potentially by mechanisms of virion-free cell-to-cell transmission(124). 
For DVGs that can be packaged into virions, not all types of DVGs may be 
efficiently packaged and transmitted. Competition assays between the paramyxovirus 
Sendai virus (SeV) DVGs of different sizes show that larger DVGs have a packaging 
advantage over smaller DVGs, likely because they are better at inducing the membrane 
curvature required for particle formation(61, 125). However, these findings do not 
exclude the possibility that high levels of replication of smaller DVGs interfere with virion 
production in other ways. Similarly, different alphavirus DVGs are more or less efficiently 
packaged into DPs when propagated or produced in different cell lines(122). 
Furthermore, DVGs may have additional requirements for budding, as is the case for 
lymphocytic choriomeningitis virus (LCMV) DVGs. The PPXY domain of the matrix 
protein, Z, can be reversibly phosphorylated, and this posttranslational modification can 
either enhance or restrict production of DPs depending on which residue is 
phosphorylated, indicating a potential mechanism for the virus to regulate DP 
generation. Interestingly, production of LCMV DPs relies on the endosomal sorting 
complex required for transport (ESCRT) pathway, whereas standard virus particles can 
be produced in the absence of ESCRT and do not require the PPXY domain(126, 127). 
1.2.3 Defective viral genomes and Disease 
1.2.3.1. Defective Particles and Disease Outcome 
Many early studies of the role of DVGs during infection were performed in the 
context of DPs. Most notably, the first studies using influenza virus showed that smaller 
noninfectious particles could influence the outcome of infection by reducing viral titers 
when the virus was grown in cell cultures or in eggs(128-130). After that, DPs for many 
other viruses were described including the negative-strand viruses SeV(131) and 
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VSV(132) and the positive-strand viruses Semliki Forest virus(133), Sindbis virus(134), 
and poliovirus(135). 
Work in the 1970s and 1980s showed that DPs influenced infection outcomes in 
mice. In infections with Semliki Forest virus(136, 137) or with influenza virus(138, 139), 
mice that received an inoculum containing high levels of DPs in addition to the standard 
virus were protected from disease and had reduced levels of viral replication and virus 
dissemination compared to those receiving standard virus alone. Production of virus 
stocks with higher levels of DPs was observed when virus was grown to high titers or 
when animals were infected with viruses that contained high levels of DPs during initial 
infection. However, because the de novo production of DPs was observed only in 
viruses grown to high titers in tissue culture, the presence of DPs in natural infections 
was questioned and progress in the field slowed. 
Work in the past decade has reexamined the role of DPs in disease outcome, 
and the original findings with orthomyxoviruses and alphaviruses have been confirmed 
and expanded to a number of additional viral families. Mice infected with stocks of SeV 
containing high amounts of DPs were protected from weight loss early during infection 
and induced stronger immune responses compared to mice infected with virus 
containing low amounts of DVGs. These findings were replicated by supplementing low 
DVG virus stocks with purified DPs, indicating that this protective effect is due to the 
addition of DPs(140). Similar observations were obtained in infections with influenza 
virus (140) or the pneumovirus RSV(141). 
The role of DPs in viral infections was also expanded to arboviruses and 
nonvertebrate hosts. Infections of Drosophila with Sindbis virus with a high content of 
DVGs survived longer than flies infected with virus with a low content of DVGs(142). 
Additionally, mosquitos infected with stocks of WNV that contained high amounts of 
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DVGs had reduced infection, viral replication, and dissemination compared to those 
infected with stocks with low levels of DVGs. Interestingly, WNV findings in mosquitos 
were not recapitulated in mice, indicating that there may be different effects of DVGs or 
DPs in different host species(143). 
Whether conclusions from infections of animal models using inocula with high 
initial levels of DPs apply to human infections is unclear. Models of interhost 
transmission describe high bottlenecks for infection where the production of thousands 
of virions from a transmitting host can lead to founding virus populations as small as a 
single virion in the receiving host(144). It therefore seems unlikely that during 
transmission a cell in a naive receiving host would be coinfected with a DP and a 
standard virus particle as this would require inoculation with a high DP to standard virus 
particle ratio. However, infections of hosts that are immunosuppressed or have 
comorbidities may increase sizes of founding populations, thereby increasing the 
probability of cells coinfected with a DP and a standard virus particle. However, initial 
infections may also occur with virions that have packaged both a DVG and a standard 
viral genome inside a single virion(71), or virions may aggregate during infection to 
enhance co-transmission, as reported for VSV(145) and poliovirus(146). Additionally, it 
is possible that DPs are independently transmitted during infection and that DVGs 
remain silent within a cell until that cell becomes infected with a standard virus before 
replicating. For paramyxoviruses, defective ribonucleoprotein complexes are stable 
within cells, in the absence of replication for up to 96 hours(147, 148). Evidence that 
DVGs are transmitted between hosts during natural infection with influenza virus comes 
from finding the same DVG RNAs in patients infected with pandemic H1N1 linked by 
direct contact(104), although this does not exclude that the same DVGs were present in 




1.2.3.2 Defective Viral Genomes and Disease Outcome in Natural Infections 
DVGs have been detected in tissues and fluids of humans and animals infected 
with influenza(104), dengue(95), hepatitis C(149), hepatitis A(150), WNV(143), or 
measles(151). However, due to a generalized belief that DVGs did not play an important 
biological role, the literature on this topic was limited to descriptive rather than 
mechanistic studies. Recently, DVGs were identified in clinical samples from respiratory 
secretions of children infected with RSV, and, importantly, their presence correlated with 
stronger innate immune responses in these patients(152). These observations 
demonstrated for the first time that naturally occurring DVGs may play an important role 
during natural infections. Further, during natural infections with influenza virus, patients 
infected with a virus containing a mutation in the polymerase basic 2 subunit of the 
polymerase were more likely to accumulate DVGs. Importantly, this variant was found 
more often in patients who recovered from the infection compared to those who were 
categorized as severely ill(107). 
1.2.4 Mechanisms of DVG Impacts on Infection 
DVGs and DPs were first discovered for their ability to interfere with standard 
virus replication and production. DVGs were first described in influenza virus infection in 
the late 1940s by Preben von Magnus and termed von Magnus particles (128, 129). 
Upon infection of the same cell as a standard virus, von Magnus particles reduced the 
production of standard virus presumably by competing for resources with the parental 
virus. Interference has been demonstrated for DVGs and DPs from a number of viruses, 
and in many cases an impact on infection outcome has been demonstrated.  
1.2.4.1 Mechanisms of interference 
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DVGs can exert interfering pressure at multiple levels during the production of 
progeny virus (Fig. 1.3). During replication, DVGs can compete for the viral polymerase 
as well as consume the nucleocapsid proteins for coating its genome. The small size of 
DVGs confers a replication advantage. In addition, in negative-sense RNA viruses the 5′ 
trailer promoter is approximately 40 times more favorable than the 3′ leader promoter, 
and as snapback or copy-back DVGs are flanked by trailer promoters, they are 
replicated at an advantage to a leader-trailer–flanked virus(153). Additionally, DVGs may 
accumulate mutations in their promoter regions, which can confer advantages over the 
standard virus. DVGs may also compete for structural proteins to be packaged into 
virions, thereby limiting the number of infectious particles produced. Particularly for 
segmented viruses, the packaging of DVGs into particles can limit levels of infectious 
particles(154). Additionally, DVGs may lead to degradation or increased turnover of viral 
proteins or suppress structural proteins required for assembly, as is the case in SeV, 
where the presence of DVGs associated with increased degradation of the viral matrix 
protein and decreased surface expression of the hemagglutinin-neuraminidase 
protein(155, 156). t 
Although the mechanisms of interference have been hypothesized and studied, 
we do not know the exact ratios of DPs that are required to completely interfere with 
standard virus replication and particle production. Additionally, it is likely that not all 
DVGs exhibit similar interfering abilities. For example, multiple types and sizes of DVGs 
from VSV can efficiently interfere with some strains of parental virus, while other parental 
strains can replicate these DVGs but do not seem to be subject to interference(157). 
Interestingly, not all types of DVGs can interfere with replication of standard virus. 
Particularly, certain strains of WNV seem to be insensitive to interference by DVGs 
(158). DVGs from WNV also show differing abilities to interfere with virus replication in a 
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host-dependent manner, with interference occurring in mosquito hosts but not mouse 
hosts(117). These differences in interference ability may be due to host intrinsic factors 
that limit DVG replication or to changes in viral replication between hosts. 
1.2.4.2 Interference and Disease Outcomes 
The role of DVGs in modulating outcome of infection can be attributed in part to 
the ability of DVGs to interfere with the standard virus and prevent damage to the host 
from viral replication. Data from influenza virus suggest that one DP is sufficient to 
temper levels of standard virus replication to levels that limit cytopathology, although the 
role that interferon induction plays in this system may confound these 
interpretations(159). Interference may play a critical role in determining disease outcome 
when animals are infected with high levels of DP-containing virus stocks or when DPs 
are given therapeutically or prophylactically. For naturally arising DVGs, the role of 
interference and how this dictates host outcome are less clear. Although interference 
could certainly play a role within an infected cell that generates a de novo DVG, whether 
there will be high-enough DPs produced in a naturally infected host is unclear. The 
levels of DPs generated in a particular host and the ratio of DPs to infectious particles 
within local foci of infection may critically determine if interference occurs at biologically 
relevant levels in vivo. 
1.2.4.3 Innate Immune Activation 
   One of the best-characterized functions of DVGs during infection is their ability to 
induce innate immune responses, including expression of interferons, interferon-
stimulated genes, cytokines, and chemokines. The primary descriptions of DVGs as 
inducers of antiviral immunity were during infections with negative-sense RNA viruses. In 
the absence of DVGs, there was no immune activation, while in the presence of DVGs at 
the onset of infection in the form of DPs, or after de novo generation in a natural 
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infection, there was strong induction of the antiviral immune response(121, 140, 141, 
160-164). In addition, not all cells engage in an immune response during viral infections, 
corresponding with the heterogeneous accumulation of DVGs within infected cells(140, 
165). In infections with SeV, cells that accumulated high levels of DVGs were the 
primary inducers of interferon as measured by interferon regulatory factor 3 nuclear 
translocation(166) and antiviral innate immune signatures obtained by transcriptome 
analysis of infected cell populations(165). 
   DVGs are strong inducers of the innate immune response by acting as strong 
pathogen-associated molecular patterns (PAMPs) during viral infection. The addition of 
purified DPs to SeV or RSV infections promotes the induction of the antiviral immune 
responses in an RLR-dependent manner(141, 163). This response is DVG specific, as 
addition of increasing amounts of standard virus is not sufficient to induce interferon to 
similar levels(140, 163, 164). Additionally, immunoprecipitation of retinoic acid-inducible 
gene-I (RIG-I) followed by RNA-seq revealed that most of the ligands bound to RIG-I 
correspond to segments within the 5′ terminus of the virus, the region from which copy-
back DVGs are formed(167). Moreover, analysis of the RNA structure of the 
predominant SeV DVG, DVG-546, found a molecular motif that enhanced binding of 
RIG-I and MDA5 to the RNA(166). DVGs produced from measles have also been shown 
to bind to RLRs (168, 169), and similar principles apply to other negative-sense RNA 
viruses. While certain well-characterized DVGs have been shown to interact directly with 
binding partners during infection, this may not be true for all DVGs. First, not all DVGs 
are equally good at inducing immune responses, as studies with SeV have shown that 
specifically copy-back DVGs induced innate immune responses compared to deletion 
DVGs or truncated DVGs(170). Second, it is unknown whether these principles 




   The features that make some DVGs such powerful PAMPs have been 
investigated. Because DVGs share most, but not all, sequence homology with standard 
virus, sequences within the DVG may facilitate RLR binding and activation, presumably 
in an RNA-secondary structure dependent manner. Data using the strongly 
immunostimulatory SeV Cantell DVG-546 support this argument(166). However, viral 
RNA from negative-sense RNA viruses is thought to be coated in nucleoprotein within an 
infected cell, as encapsidation is required for replication, thereby preventing RLRs from 
accessing the viral RNA. Analysis of measles virus indicated that the lack of 
encapsidation is critical for the induction of innate immune response by DVGs(168), 
suggesting that non-encapsidated viral RNA may exist in infected cells. Further, it has 
been suggested that SeV DVGs are generated by viruses that encode a variant of the 
nucleoprotein that binds viral RNA less tightly(171), potentially exposing viral RNA to 
pattern recognition receptors. To reconcile the need for encapsidation for replication and 
the lack of encapsidation for immune stimulation, a subset of DVGs may be uncoated 
and stimulate immunity and another subset may be fully coated and replicate potentially 
exerting interfering pressure. Whether this occurs in the same cell or there are certain 
cells that contain non-encapsidated DVGs is unknown, but as only a subset of cells 
elicits an interferon response upon infection, it may be that only a subset of DVGs is able 
to elicit immune responses. 
Another explanation for the ability of DVGs to rapidly induce the antiviral immune 
response is their ability to interfere with the expression of viral-encoded antagonists. 
Lack or low expression of viral-encoded antagonists allow the virus to trigger an immune 
response. However, induction of interferon by DVGs during SeV infections occurs before 
viral-encoded antagonists accumulate to high levels(163, 164). Additionally, comparison 
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between antagonist proteins in different strains of SeV that differ in their interferon-
inducing abilities showed no difference in ability to antagonize interferon induction in 
transfection-based assays, further supporting the claim that absence of viral antagonism 
is not responsible for DVG induced immune responses(171). 
Interestingly, interferon antagonists of paramyxoviruses have been shown to limit 
DVG generation. The accessory protein C found in paramyxoviruses such as measles, 
Human parainfluenza viruses type 1 and 3, and SeV antagonizes the innate immune 
response by preventing signal transducer and activator of transcription 1 (STAT1) 
phosphorylation. The presence of C limits DVG accumulation, as recombinant viruses 
that lack expression of these proteins produce very high levels of DVGs even when 
passaged at low multiplicity of infection(118, 119). How C proteins act to limit DVG 
generation or accumulation is not known, but it may be related to the role that C proteins 
play in altering polymerase preferences for RNA templates(31). Unpublished data from 
our lab show that cells that accumulate high levels of DVGs during infection have very 
low levels of C expression, but whether a lack of C leads to the accumulation of DVGs or 
whether the accumulation of DVGs limits expression of C is yet to be determined. In fact, 
these two options are not mutually exclusive, and antagonist or accessory proteins and 
DVGs may have multiple levels of coregulation. 
1.2.5 Defective Viral Genome–Induced Heterogeneity in Infection 
 During infections with virus stocks containing DPs some cells accumulate high 
levels of DVG RNA while others accumulate predominantly full-length virus RNA(165). 
The causes of this heterogeneity are not fully understood but it may be related to the 
initial input ratio of DPs to standard virions. (Figure 1.5). Additionally, there is 
heterogeneity among cells infected with standard virus that go on to produce de novo 
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DVGs(172). This type of heterogeneity may also be driven by input virus levels (as 
DVGs are more prone to generation under high multiplicity of infection conditions) or by 
host intrinsic factors that regulate DVG production. 
The heterogeneity in viral nucleic acid accumulation during infection is important 
due to the differing functional outcomes of infected cells. In infections with SeV and 
RSV, cells that accumulate high levels of DVGs induce a potent immune response 
through retinoic acid-inducible gene-I-like receptors (RLRs) signaling and produce 
 
Figure 1.5 DVG and standard virus dynamics during infection progression. (1) Low DVG 
infections will eventually lead to the de novo generation of DVGs within a cell, presumably in 
cells infected at a high multiplicity of infection or supporting high levels of viral replication. (2) 
Once DVGs are generated, they will accumulate and be released from the cell as DPs. DVG 
will then propagate in neighboring cells infected with standard virions. (3) Once high levels of 
DVGs have accumulated and sufficient DPs have been released, local foci of infection will 
become heterogeneous, with cells having low, intermediate, or high levels of DVGs depending 
on infection ratios of DPs to standard virions. (4) As DVGs and DPs accumulate, some cells 
receiving high levels of DPs will become DVG high and induce the production of interferons 
and cytokines but fail to produce virus or DPs. Progression of low DP infections, presumably 
upon natural transmission, will occur from stages 1 to 4. Infection with viral stocks containing 
high levels of DVGs or during high particle transmission events will progress from 3 to 4. 
Therapeutic or prophylactic administration of DPs will likely result uniquely in stage 4. 
Abbreviations: DP, defective particle; DVG, defective viral genome. Figure published in (92). 
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interferons, interferon-stimulated genes, cytokines, and chemokines(165, 166). The 
triggering of RLRs also stimulates the expression of pro-survival tumor necrosis factor 
(TNF) family member proteins and protects these cells from TNF-mediated cell death, 
while cells that are enriched in full-length virus are killed by TNF released from DVG-
high cells(165). Heterogeneity in induction of immune responses has also been shown 
for other viruses, such as influenza, through single-cell RNA sequencing of cellular 
mRNA and viral RNA (172, 173). 
In addition to heterogeneity of initiation of immune responses, there is also 
heterogeneity in the ability of infected cells to produce standard and defective viral 
particles. During infections with VSV, virus particle production is variable when single 
cells are examined compared to a bulk population(174). When DPs are added at varying 
amounts, the heterogeneity in standard virus production increases. Examination of 
single cells revealed that cells vary from producing no virus to producing low or high 
levels of virus depending on the input ratio of DPs to standard virus(174, 175). Taken in 
concert with the idea that these full-length high cells die promptly in infections, while 
DVG-high cells survive, these observations raise intriguing questions as to the dynamics 
at play within cells with different contents of DVGs during virus persistence and virus 
transmission.  
1.3 Experimental Questions 
The López lab has long used the murine parainfluenza virus, Sendai virus, as a 
model to study the impact of defective viral genomes during infection particularly on the 
initiation of the immune response and on the outcomes of infection in mouse 
models(140, 141, 163-166). In order to study the impact of DVGs on paramyxovirus 
infection at an intracellular level, we developed an RNA fluorescence in situ hybridization 
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(FISH) approach that enabled us to distinguish full-length from defective viral genome 
RNA. This approach allowed for the visualization of DVGs during infection, which had 
previously been difficult due to their sequence homology with the standard virus. Using 
this technology, we observed that upon infection with SeV viral stocks containing high 
levels of defective particles, there is heterogeneity in the accumulation of DVGs amongst 
cells, with some cells accumulating high levels of DVGs and some cells accumulating 
high levels of full-length virus. These distinct cellular phenotypes were characterized by 
RNA-seq and indicated that these cells engage distinct transcriptional profiles with DVG-
high cells having a pro-inflammatory and pro-survival pathway upregulated in contrast to 
FL-high cells which had cellular stress and unfolded protein response pathways 
upregulated(165). 
In addition to distinct transcriptional status and cell fates of these cells, we 
observed that the intracellular localization of viral RNAs in these cells was distinct. While 
full-length virus high cells have viral RNA that clusters in a perinuclear region, DVG-high 
cells display viral RNA diffusely throughout the cytoplasm. This observation led to 
several questions that are the driving motivation for this work, including what the 
mechanisms of this differential localization are and how does this differential localization 
impact the viral lifecycle during infection. We hypothesized that discrete localizations of 
viral RNA would impact viral particle production due to differential engagement with 
pathways coopted for virion assembly and that this differential engagement with the host 
is driven by different levels of accumulation of viral proteins.  
In Chapter 2, I will discuss the characterization of the intracellular localizations of 
viral genomes in these two distinct cell populations. We asked which host factors viral 
genomes engage with in these cellular subsets and found that viral genomes in FL-high 
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cells engage with the Rab11a marked recycling endosomes, while viral genomes in 
DVG-high cells do not. I will then explore how these differences in localization impact 
particle production, as the Rab11a pathway is critical to initial steps in virion assembly.  
In Chapter 3, I will take advantage of the heterogeneity in viral engagement with 
the host cell to parse replication and particle assembly to identify critical viral proteins 
required for engagement with Rab11a. I will examine the role of M and NP proteins as 
well as C protein and the viral polymerase L in during SeV infection in order to better 
understand which viral proteins are required for interaction with Rab11a. 
Overall, this work seeks to understand the impacts of heterogeneous 
distributions of DVGs in SeV infections on particle production and infection dynamics 









CHAPTER 2: Defective viral genomes alter how Sendai virus 
interacts with cellular trafficking machinery leading to heterogeneity in 
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Defective viral genomes (DVGs) generated during RNA virus replication 
determine infection outcome by triggering innate immunity, diminishing virulence, and, in 
many cases, facilitating the establishment of persistent infections. Despite the critical 
role of DVGs during virus-host interactions, the mechanisms regulating production and 
propagation of DVGs are poorly understood. Visualization of viral genomes using RNA 
fluorescent in situ hybridization revealed a striking difference in the intracellular 
localization of DVGs and full-length viral genomes during infections with the 
paramyxovirus Sendai. In cells enriched in full-length virus, viral genomes clustered in a 
perinuclear region and associated with cellular trafficking machinery, including 
microtubules and the GTPase Rab11a. However, in cells enriched in DVGs, defective 
genomes distributed diffusely throughout the cytoplasm and failed to interact with this 
cellular machinery. Consequently, cells enriched in full-length genomes produced both 
DVG and full-length genome-containing viral particles, while DVG-high cells poorly 
produced viral particles, yet strongly stimulated antiviral immunity. These findings reveal 
the selective production of both standard and DVG-containing particles by a 
subpopulation of cells during infection that can be differentiated by the intracellular 
localization of DVGs.  This study highlights the importance of considering this functional 
heterogeneity in analyses of virus-host interactions during infection. 
2.2 Significance 
 Defective viral genomes (DVGs) generated during Sendai virus infections 
accumulate in the cytoplasm of some infected cells and stimulate antiviral immunity and 
cell survival. DVGs are packaged and released as defective particles and have a 
significant impact on infection outcome. This chapter shows that the subpopulation of 
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DVG-high cells poorly engages the virus packaging and budding machinery and do not 
effectively produce viral particles. In contrast, cells enriched in full-length genomes are 
the primary producers of both standard and defective viral particles during infection. This 
study demonstrates heterogeneity in the molecular intracellular interactions occurring 
within infected cells and highlights distinct functional roles for cells as either initiators of 
immunity or as producers and perpetuators of viral particles depending on their content 
and intracellular localization of viral genomes. 
2.3 Introduction 
Defective viral genomes (DVGs) are the primary immunostimulatory molecules 
during infection, both in vitro and in vivo, and stimulate a cellular pro-survival program 
that facilitates the establishment of persistent infections (140, 164, 165, 176). 
Additionally, DVGs occur in natural infections in humans, likely impacting the infection 
outcome (107, 141). However, despite their critical role during virus-host interactions, the 
mechanisms regulating DVG production and propagation are poorly understood. The 
presence of DPs within viral stocks amplified in the laboratory is nearly ubiquitous and 
for decades it has been assumed that all infected cells produce DPs upon reaching a 
high titer of virus replication (95, 177-183). However, we have reported remarkable 
heterogeneity in the accumulation of DVGs within a subset of cells during infection with 
the model paramyxovirus Sendai (SeV). This heterogeneity is associated with distinct 
functions of the DVG-high cell population, including the induction of antiviral immunity 
(140, 164, 166) and the facilitation of viral persistence via the induction of a pro-survival 
cellular program (165). In contrast, cells containing low or no DVGs had a negligible 
contribution to these processes. This evidence, together with recent evidence of 
heterogeneity in both viral replication and particle production of other RNA viruses (172, 
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174, 184-186) led us to investigate how DVGs impacted the production of both DPs and 
standard viral particles.  
Using RNA fluorescent in situ hybridization (FISH) that allows us to distinguish 
defective and full-length (FL) viral genomes within infected cells, we discovered that in 
addition to heterogeneity in the amount of DVGs among infected cells, viral genomes 
localized to different intracellular spaces in DVG-high and FL-high cells. Importantly, this 
differential localization critically impacted the ability of viral RNPs to interact with the 
cellular machinery used to produce viral particles. As a result, DVG-high cells had a 
drastically reduced production of both standard and defective viral particles compared to 
FL-high cells. This study reveals two functionally distinct populations during SeV 
infection that can be distinguished by the amount and intracellular localization of DVGs. 
In addition, together with published evidence of a critical role for DVGs in driving innate 
immunity, this study highlights the critical importance of considering the remarkable 
division of labor among infected cells in the study of virus-host interactions.  
2.4 Results 
2.4.1 DVGs alter the intracellular distribution of viral ribonucleoprotein (vRNP) during 
infection  
To investigate if the presence of DVGs altered the interactions of vRNPs with 
cellular components, we first assessed whether DVGs changed the localization of viral 
ribonucleoproteins (vRNPs) in infected cells. To do this, we infected cells with stocks of 
SeV strain Cantell depleted of DVGs (SeV-LD) at MOI 1.5 TCID50/cell (HAU of 3 per 
5x105cells) and supplemented the infections with increasing HAU doses of purified DPs 
containing the SeV Cantell DVG-546 (Fig 2.1A-E). Sendai virus Cantell strain naturally 
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produces one specific DVG 546 nucleotides in length, making this an ideal system for 
identifying DVGs by PCR (140, 170). We measured the levels of DVG-546 in infected 
cells by RT-qPCR and found that amount of DVG-546 increased corresponding to 
greater doses of DP as expected (Fig 2.1B).  Since viral RNA is associated with 
nucleoprotein (NP) to form vRNPs (187), visualization of NP protein was used as an 
initial proxy for vRNPs. Using a stock of virus with low contents of DVGs (SeV-LD + pDP 
HAU 0), we noted that NP accumulates in a perinuclear region of the infected cell. 
However, upon addition of increasing doses of DPs during infection, there was a dose-
dependent increase in cells that display a cytoplasmic and diffuse NP staining with a 
corresponding loss of cells that have predominantly perinuclear NP (Fig 2.1A). To 
quantify these differences, we assessed the size of the area occupied by NP per 
infected cell and determined that NP became more spread out throughout the cell 
cytoplasm with increasing amounts of DVG (Fig 2.1C). Importantly, we also used 
immunofluorescence to quantify amount of NP within infected cells and determined that 
presence of DVGs did not decrease the amount of NP within infected cells when imaged 
at a per cell basis (Fig 2.1D). However, the number of cells that were productively 
infected decreased significantly with the addition of increasing amounts of DPs (Fig 
2.1E), likely explaining the reported reduction in NP production in cell populations 
infected in the presence of DVGs (140). 
Next, we examined the localization of SeV NP in the presence of DVGs over 
time. To do this we infected cells with SeV-LD (Fig 2.1F) or with SeV containing DVGs 
at levels similar to SeV-LD + pDP HAU 20 (SeV-HD), and compared NP distribution. 




Figure 2.1. Defective viral genomes alter viral nucleoprotein distribution within infected 
cells. (A) A549 cells infected with SeV-LD MOI 1.5 TCID50/cell supplemented with purified DPs at 
indicated HAU, for 24 h and stained for SeV NP (grey) and nuclei (blue). Images captured at 40X, 
wide field. Images are representative of 3 independent experiments. Scalebar = 100μm. (B) RT-
qPCR of SeV (+)DVG-546 relative to GAPDH. (C) Percentage of cells per field that are NP+ as 
determined by level of fluorescence above background (D) Quantification of SeV NP amount by 
fluorescence intensity and (E) distribution of NP by Pixel area within individual cells at 24 h post 
infection. Results show sum of 3 independent experiments with >250 individual cells analyzed per 
condition. Individual cells are plotted with a line at mean, error bar represents ± SEM **** = p < 
0.0001 by Kruskal-Wallis test, with Dunn’s multiple comparisons test. (F) A549 cells infected with 
SeV-LD and (G) SeV-HD for indicated time points and stained for SeV NP (grey) and nuclei (blue). 
Images captured at 63X, wide field. Images are representative of four independent experiments. 
Scalebar = 100μm. (H) RT-qPCR for SeV NP, (+)gSeV and (+)DVG-546 relative to GAPDH. Data is 
represented as mean ± SEM of three independent experiments, ** = p< 0.005, * = p<0.05 by two-
way ANOVA with significance indicated between viral infections.  
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detectable levels. At this time point, in cells infected with SeV-LD, NP began to uniformly 
accumulate in a perinuclear region. This distribution was maintained until at least 36 h 
post infection (Fig 2.1F). In contrast, SeV-HD infections demonstrated heterogeneity in 
the distribution of NP throughout the time points analyzed (Fig 2.1G). As expected for 
bulk population analysis, HD infections showed lower levels of FL genomes and SeV NP 
mRNA and higher levels of DVGs compared to LD infections (Fig 2.1H), though as 
mentioned earlier bulk population analysis may confound the interpretation of these 
data, artificially lowering values of SeV NP levels on a per cell basis. These data 
demonstrate that the presence of DVGs during infection alter the intracellular distribution 
of NP independent of changes on its transcription. 
2.4.2 DVGs and full-length genomes localize disparately in infected cells.  
Because the addition of DPs to viral infections altered the intracellular localization 
of viral NP, we next investigated and differentiated the intracellular distribution of DVG-
containing vRNPs and FL-genome containing vRNPs using RNA fluorescent in situ 
hybridization (RNA FISH). Probes targeting the 5’- end of the (+)-sense genome colored 
red and probes targeting the 3’- end of the (+)-sense genome pseudo-colored green 
were used to distinguish DVGs in green and FL viral genomes as orange (hybridizing 
both red and green probes), as we have described (165) (Fig 2.2A). RNA-FISH of cells 
infected with SeV-LD or SeV-LD plus increasing amounts of purified DPs confirmed that 
FL genomes and DVGs accumulate in different cells and that their intracellular 
distribution is distinct (Fig 2.2B). In SeV-LD infections, FL genomes were clustered in a 
perinuclear region and addition of DPs resulted in the appearance of DVG-high cells with 




Figure 2.2. FL genomes accumulate in a perinuclear region while DVGs are distributed 
throughout the cytoplasm. (A) Schematic of (+) and (-) sense probe sets binding to SeV 
genomes and anti-genomes. For (+) sense FISH: probes targeting the 5’ end of (+) genome are 
shown in red, probes targeting the 3’ end of (+) genome are shown in green, interpreted as: 
+gSeV (orange), +DVG (green). For (-) sense FISH: probes targeting the 3’ end of (-) genome are 
shown in red, probes targeting the 5’ end of (-) genome are shown in green, interpreted as: -gSeV 
(orange), -DVG (green). (B) A549 cells infected with SeV-LD MOI 1.5 TCID50/cell supplemented 
with purified DPs at indicated HAU for 24 h followed by (+)-sense viral RNA FISH. Images 
captured at 40X, wide field. Images are representative of 3 independent experiments, scalebar = 
100μm. (C) A549 cells infected with SeV-HD for 24 h then subjected to (+)-sense viral RNA FISH 
or (-)-sense viral RNA FISH. 63X wide field, deconvolved, extended focus is shown. Images are 
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increased, the number of FL-high cells decreased while the number of DVG-high cells 
with cytoplasmically distributed DVGs increased.  
Because probes targeting (+)-sense viral RNA may also hybridize to mRNA, a 
set of probes targeting the negative sense genome was used to confirm a distinct 
distribution of DVGs and FL genomes in the absence of mRNA labeling. Probes 
targeting the 3’- end of the (-)-sense genome colored red and probes targeting the 5’- 
end of the (-)-sense genome pseudo-colored green were used to distinguish DVGs in 
green and FL viral genomes as orange (hybridizing both red and green probes) (Fig 
2.2A). During infection with SeV-HD (+)-strand probes identified a heterogeneous 
population of cells, those that accumulate viral genomes in a perinuclear region and 
those that accumulate DVGs diffusely in the cytoplasm, similar to what was observed in 
infections with SeV-LD plus DPs (Fig 2.2B-C). Infections with SeV-HD generate distinct 
subpopulations comprising ~30% DVG-high cells and 30% FL-high cells in A549 cells at 
24 h post infection. Similarly, (-)-strand probes identified perinuclear viral genomes and 
cytoplasmic DVGs (Fig 2.2C) indicating that the observed disparate distributions apply 
to viral genomes regardless of their sense.  
2.4.3 DVG cytoplasmic distribution is independent of their size or sequence  
In order to address whether the cytoplasmic distribution of DVGs was due to 
properties of the viral genomes, we asked whether this distribution was unique to SeV 
Cantell DVGs. This virus strain produces a single 546-nt long cbDVG that is strongly 
immunostimulatory (164, 166, 170). Other strains of SeV produce cbDVGs of different 
lengths and sequence and their immunostimulatory activity vary (140, 170). SeV 52 




produces larger and less immunostimulatory DVGs than SeV Cantell. We generated a 
stock of SeV 52 enriched with DVGs (SeV-52-HD) by passaging the parental strain 
undiluted in eggs. This stock had 
two major DVGs, both longer than 
DVG-546 and show  
as two larger amplicons when 
amplified with a common set of 
primers (Fig 2.3A). Infections with 
SeV-52-HD revealed cytoplasmic 
distribution of DVGs similar to SeV 
Cantell infections (Fig 2.3B), 
indicating that the differential 
distribution of FL genomes and 
DVGs is common to multiple 
cbDVG types and independent of 
size or sequence.  
 
2.4.4 Cytoplasmic diffusively distributed DVGs RNPs do not interact with the Rab11a / 
microtubule intracellular trafficking machinery 
vRNPs from paramyxoviruses and orthomyxoviruses interact with Rab11a and 
utilize microtubules to facilitate particle production (45). To test whether SeV DVGs and 
FL genomes interacted similarly with this intracellular trafficking machinery, we 
performed immunofluorescence for SeV NP as a proxy for vRNPs, in conjunction with 
 
Figure 2.3. Different species of SeV DVGs are 
cytoplasmically distributed. A549 cells were infected 
with indicated virus for 24 h. (A) Agarose gel 
electrophoresis of PCR amplification of DVGs using 
common primers targeting all copy-back DVGs. (B) 
A549 cells infected with SeV- 52-LD or -HD then 
subjected to (-) sense-viral RNA FISH. Images 
captured at 63X, widefield, deconvolved. Extended 
focus is shown. Images are representative of three 














antibodies targeting a variety of cellular organelles and cytoskeletal components in FL-
high cells or DVG-high cells. FL-high cells (shown as cells with perinuclear distributed 
NP) showed strong colocalization of vRNP with Rab11a and microtubules. However, 
DVG-high cells (cells with cytoplasmically distributed NP) showed almost no 
colocalization between SeV NP and Rab11a or microtubules (Fig 2.4). These data  
suggest that vRNPs in DVG-high cells do not interact with the host intracellular 
trafficking machinery in the same manner as in FL-high cells. Further, cytoplasmically 
distributed NP did not colocalize with mitochondria, the cis-golgi, or the endoplasmic 
 
Figure 2.4. SeV NP colocalizes with Rab11a and microtubules in FL-high cells but not in DVG-high 
cells. A549 cells were infected with SeV-LD or SeV-HD for 24 h. Cells were fixed and subjected to 
immunofluorescence for viral protein SeV NP (red) and Rab11a (recycling endosomes), α-tubulin 
(microtubules), Tom-20 (mitochondria), GM130 (cis-Golgi), or Calnexin (endoplasmic reticulum) (all in 
green). Images captured at 100X, confocal. Single plane is shown. SeV LD infection was used to capture 
FL-high cells and DVG-high cells were captured from a SeV HD infection focusing on fields with cells 
containing majority cytoplasmically distributed SeV NP. Scalebar = 50μm. Global Pearson’s 
Colocalization quantified by field for 3 independent experiments, >5 fields per experiment, ** = p < 0.005, 
**** = p < 0.0001 by student’s t-test. 
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reticulum (Fig 2.4) indicating that DVG RNPs are likely not tethered to organelles within 
the cytoplasm. To further confirm that DVG RNPs do not interact with Rab11a in DVG-
high cells, we used combined immunofluorescence and RNA-FISH on cells infected with 
SeV-HD to identify vRNPs and Rab11a in FL-high and DVG-high cells (Fig 2.5A). For 
analysis, cells were binned as DVG-high or FL-high depending on their ratio of 5’-probe  
to 3’-probe to the (-)-sense 
genome and Global Pearson’s 
correlation of colocalization was 
assessed for individual cells (Fig 
2.5B). Similarly to what was 
observed when tracking NP (Fig 
2.4), data indicate that within an 
infection in the presence of DVGs, 
viral genomes in the subpopulation 
of FL-high cells containing 
perinuclearly localized vRNPs 
interact with Rab11a, but in DVG-
high cells with DVG RNPs 
distributed throughout the 
cytoplasm there is no significant 
co-localization of RNPs with 
Rab11a.  
  To next investigate whether the interaction of vRNPs with the 
microtubule/Rab11a machinery indicated functional interactions, we first disrupted 
 
 
Figure 2.5. DVG-high cells show less colocalization 
with Rab11a than FL-high cells. (A) 
Immunofluoresence for Rab11a (magenta) with (-) 
sense viral RNA FISH of A549 cells infected with SeV-
HD for 24 h with Hoechst staining nuclei (blue). Images 
captured at 63X, confocal, deconvolved, extended 
focus is shown, scalebar = 50μm. Single channel 
image of Rab11a (bottom) and RNA FISH (top) with 
Hoechst are shown to the right. (B) Global Pearson’s 
Colocalization between Rab11a and 5’ end of genome 
quantified per cell for 3 independent experiments, 5 
fields per experiment. Cells were binned as DVG+ or 
FL+ based on ratio of 5’/3’ probe intensity. Individual 
cells are plotted with a line at mean, error bar 




microtubule polymerization and tested if localization of viral genomes changed. To 
disrupt microtubules, cells were infected with SeV-HD for 4 h to allow for virus entry and 
then treated with the microtubule disrupting drug nocodazole. RNA FISH was performed 
24 h post infection to assess viral genome distribution (Fig 2.6A). Nocodazole disrupted 
the localization of FL genomes in FL-high cells agreeing with their colocalization with 
microtubules, but did not alter the localization of DVGs in DVG-high cells. FL genomes 
redistributed to discrete cytoplasmic clusters while DVGs remained diffused throughout 
the cytoplasm, indicating that they were not tethered to microtubules. Levels of SeV NP 
transcripts (Fig 2.6B) and genomic SeV RNA (Fig 2.6C) did not change upon 
nocodazole treatment, confirming that intracellular viral replication was not affected by 
the drug; however, DVG replication levels were reduced upon nocodazole treatment (Fig 
2.6C), potentially due to nocodazole’s effects on tubulin, which has been shown to 
influence SeV genomic and DVG RNA replication (188). Further, when cells depleted of 
Rab11a by siRNA knockdown were infected with SeV-HD for 24 h, FL genomes failed to 
localize to the perinuclear region and instead distributed throughout the cytoplasm, but 
the distribution of DVGs remained the same (Fig 2.6E). Rab11a knockdown was 
confirmed by testing for mRNA levels (Fig 2.6F) and protein expression using western 
blot (Fig 2.6J). Viral replication was equivalent or increased in knockdown cells, likely 
due to impaired particle production and consequent accumulation of viral genomes and 
DVGs in the cell (Fig 2.6G-I). As expected, Rab11a knockdown decreased levels of 
infectious virus production compared to controls (Fig 2.6K). In order to investigate 
whether there was a similar impact on the production of defective particles, supernatant 
from control or Rab11a-knockdown infected cells were added to LLCMK2 cells and 
levels of intracellular DVGs were measured by RNA. Because Rab11a knockdown 
reduced infectious virus production, LLCMK2 infections were adjusted to MOI 1 using 
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supplemented SeV LD. Interestingly, DVG-RNA levels in LLCMK2 cells treated with 
supernatants from infected Rab11a knockdown cells were reduced compared to cells 
treated with supernatants from infected control cells (Fig 2.6L) indicating that production 
of defective particles were reduced in the absence Rab11a, while levels of SeV  
 
Figure 2.6. Cytoplasmic distribution of DVGs in DVG-high cells is independent of 
microtubule integrity and Rab11a expression. (A) A549 cells infected with SeV-HD, treated 
with nocodazole at 4 h post infection, (+) sense viral RNA FISH performed at 24 h post infection. 
Images captured at 63X, widefield, deconvolved. Extended focus is shown. Scalebar = 100μm. 
Images are representative of four independent experiments.  RT-qPCR for (B) SeV NP, (C) 
(+)gSeV and (D) (+)DVG-546 transcripts relative to GAPDH at 24 h post infection. Data is 
represented as mean ± SEM of three independent experiments, * = p < 0.05 by paired t-test. (C) 
A549 cells transfected with siRNA targeting Rab11a or scrambled control siRNA (siCtrl) prior to 
infection, infected with SeV-HD for 24 h, then subjected to (+) sense viral RNA FISH. Images 
captured at 63X, widefield, deconvolved. Extended focus is shown. Scalebar = 100μm. Images 
are representative of four independent experiments. RT-qPCR for (F) Rab11a, (G) SeV NP (H) 
(+)gSeV, and (I) (+)DVG-546 transcripts relative to GAPDH at 24 h post infection, data is 
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represented as mean ± SEM of seven independent experiments, * = p < 0.05, ** = p < 0.005 by 
paired t-test. (J) Western blot for Rab11a protein with GAPDH loading control. (K) Relative levels 
of infectious virus by TCID50 normalized to siRNA control, data is represented as mean ± SEM of 
three independent experiments, * = p < 0.05 by paired t-test. Supernatant from control siRNA and 
Rab11a siRNA KD cells was adjusted to MOI 1 TCID50/cell with SeV LD and LLCMK2 cells were 
infected for 24 h. RT-qPCR for Cantell specific DVG-546 (L), (+)gSeV (M) and SeV NP (N) 
mRNA relative to GAPDH, data is represented as mean ± SEM of three independent experiments 
normalized to SeV LD alone. ** = p <0.005 by One-way ANOVA, Bonferroni post-hoc. 
transcription and genomic SeV RNA were the same across infections (Fig 2.6M-N).  
Taken together, these results indicate that within an infection, vRNPs in FL-high cells 
interact with cellular trafficking machinery involved in virus packaging and budding, while 
RNPs in DVG-high cells are localized differently than in FL-high cells and fail to interact 
with the cellular machinery used for paramyxovirus budding and particle production.  
2.4.5 Virions containing FL genomes or DVGs are produced by FL-high cells and not by 
DVG-high cells 
Because of the documented importance of Rab11a/microtubule trafficking 
pathways for paramyxovirus particle production (45), we next asked if DVG-high cells 
produced defective viral genome containing particles (DPs). Taking into consideration 
the heterogeneity in viral genomic content among cells infected with SeV-HD (165) (Fig 
2.2) we live sorted DVG-high and FL-high cells to obtain enriched populations. To do 
this, we took advantage of previous data from our laboratory that identified a subset of 
TNF-associated genes that are upregulated in DVG-high cells, including the cell surface 
molecule 4-1BB (165). In addition, the SeV HN protein is a surface protein whose 
content in infected cells surface is lower in DVG-high cells than FL-high cells (156). 
Notably however, even cells with lower levels of HN (HN-low gate) are sufficient to 
produce viral particles as sorted SeV-LD infected cells produce similar amounts of 
infectious particles from both gates (Fig 2.7A-B). To study viral particle production, 
experiments were performed in LLCMK2 cells, which more robustly produce virus  
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compared to A549 cells. LLCMK2 
cells were infected with SeV-HD, 
stained and gated based on their 
expression of 4-1BB and SeV HN 
for sorting (Fig 2.7C). Sorted 
populations were characterized by 
RNA FISH (Fig 2.7D) and 
compared to unsorted population 
controls (Fig 2.7E) and relative 
genomic content was confirmed 
by RT-qPCR (Fig 2.7F). Sorted 
cell populations were cultured for 
24 h before analyzing their 
supernatant for presence of 
infectious virus and DPs. As 
expected, infectious virus was 
predominantly found in the 
supernatant of FL-high cells (Fig 
2.7G). Because low levels of DPs 
are not detectable by titration nor by hemagglutination, the content of DPs was assessed 
after amplification in LLCMK2 cells. To do this, LLCMK2 cells were infected with a 
combination of SeV-52-LD and supernatants from the cultured sorted populations. To 
confirm that SeV-52-LD was able to support replication of SeV Cantell DVG-546, purified 
DPs (HAU 20) were added to SeV-52-LD MOI 1.5 TCID50 infections and levels of DVG-
546 (Fig 2.8A) and genomic SeV (Fig 2.8B) were analyzed and showed an increase  
 
Figure 2.7. Infectious virus is produced by FL-virus 
high cells and not by DVG-high cells. (A) 
Representative flow cytometry plot of SeV LD infected 
LLCMK2 cells, 24 h post infection. HN-low shown in 
green, HN-high gate shown in red. (B) TCID50/25ul of 
supernatant from indicated cell populations. (C) 
Representative flow cytometry plot of SeV HD infected 
LLCMK2 cells, 24 h post infection. DVG-high gate 
shown in green, FL-high gate shown in red. (D) cytospin 
of indicated populations post-sorting and (E) unsorted 
SeV HD infected LLCMK2 cells as control subjected to 
(+) sense RNA FISH, widefield, 20X. (F) Relative ratio 
of DVG to genome calculated by RT-qPCR for DVG-
546 and +-sense genome in each population, relative to 
GAPDH, n = 4, Mann-Whitney non-parametric U-test, * 
= p<0.05. (G) TCID50/25ul of supernatant from indicated 
cell populations, n = 3, student’s t-test, ** = p<0.005.  
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over time. Upon infection of 
LLCMK2 with sorted cell 
supernatants, intracellular levels 
of SeV Cantell-specific DVG-546 
were analyzed 24 h post infection 
by RT-qPCR.  Interestingly, 
despite the abundance of 
intracellular DVGs, supernatant 
from purified DVG-high cells did 
not contain DVG-546 DPs, as 
there was no difference in the 
levels of DVGs in SeV-52-LD plus 
DVG supernatant compared to 
SeV-52-LD alone. Rather, DVG-
546 DPs were present in the 
supernatant from purified FL-high 
infected cells (Fig 2.8C), however 
there was no difference in levels 
of genomic SeV RNA (Fig 2.8D). 
Because we chose to amplify the 
supernatants in LLCMK2 cells to see robust virus replication, levels of IFNB and IFIT1 
are lower than in A549, as LLCMK2 cells are rather poor inducers of interferon. 
However, as expected, the presence of DPs correlated with increased expression of 
IFNB and IFIT1 mRNA (Fig 2.8E-F) compared to mock levels. Together with published 
evidence of a critical role for DVG-high cells in engaging the antiviral response, these 
 
Figure 2.8. Defective particles are produced by FL-
virus high cells and not by DVG-high cells. Purified 
defective particles added to SeV-52 and levels of (A) 
(+)DVG=546 and  (B) (+)gSeV were measured at 6 and 
24 h post infection. Three independent experiments are 
shown, * = p<0.05, *** = p < 0.001, by two-way ANOVA 
Sidak’s multiple comparisons.  Supernatant from sorted 
cells was mixed with SeV 52 at MOI 1.5 TCID50/cell and 
LLCMK2 cells were infected for 24 h. RT-qPCR for (C) 
Cantell specific DVG-546, (D) (+)gSeV, (E)  IFNB, and 
(F) IFIT1 mRNA relative to GAPDH, n = 3, one-way 
ANOVA, Bonferroni post-hoc, ** = p <0.005. 
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data demonstrate the distinct functional properties of different cells during viral infections 
and identify viral particle production as a distinctive function of FL-high cells.  
2.4.6 DVG cytoplasmic distribution is independent of antiviral signaling and cell type 
DVGs from SeV Cantell strongly stimulate the RIG-I-like-receptor (RLR) pathway 
and induce the expression of type I and III IFNs and hundreds of interferon stimulated 
genes (164, 166, 167, 170). Agreeing with the well-known immunostimulatory activity of 
DVGs (90), SeV-HD infections showed robust induction of antiviral responses compared 
to SeV-LD infections, including high levels of expression of IFNB and the interferon 
stimulated gene IFIT1 (Fig 2.9A-B). To assess if these host responses impacted the 
differential distribution of FL genomes and DVGs and consequent different DP 
production levels (Fig 2.8), we used CRISPR knockout cell lines lacking the RLR 
signaling adaptor mitochondria antiviral signaling protein (MAVS KO), or lacking the type 
I IFN receptor (IFNAR KO). Intracellular distribution of FL-genomes and DVGs in 
knockout cell lines was similar to their distribution in control cells at 24 h post SeV 
infection (Fig 2.9C-E) indicating that cytoplasmic distribution of DVGs in DVG-high cells 
is independent of both RLR and IFN signaling. To investigate whether DVG distribution 
was dependent on other host factors, we tested a variety of cell lines from various host 
species. Infection of SeV in various adherent epithelial non-human cell lines, including 
monkey LLCMK2 cells, which support robust replication of virus and are traditionally 
used for virus growth and titration, Marine Darby Canine Kidney (MDCK), and Vero cell 
lines recapitulated the phenotype seen in A549 cells (Fig 2.7E and data not shown). The 
independence on anti-viral signaling and host cell type indicate that the intracellular 
distribution of vRNPs in FL-high and DVG-high cells is likely virally driven process, the 




Figure 2.9. Differential distribution of viral genomes is independent of antiviral signaling. 
(A) RT-qPCR for IFNB and IFIT1 (B) mRNA relative to GAPDH, n = 3, one-way ANOVA, 
Bonferroni post-hoc, ** = p <0.005. (C) CRISPR control A549, (D) MAVS KO, and (E) IFNAR KO 
cell lines were infected with SeV-HD for 24 h then subjected to (+)-sense viral RNA FISH. Images 
captured at 63X, widefield, deconvolved. Extended focus is shown. Images are representative of 
three independent experiments, scalebar = 50μm. 
2.5 Discussion 
Our data indicate that cells that accumulate high levels of DVGs during an 
infection have a distinct cytoplasmic distribution of vRNPs compared to infected cells 
that do not accumulate high levels of DVGs, and these RNPs do not engage with the 
host cell to produce virions or DVG-containing defective particles (DPs). In contrast, FL-
genome and DVG vRNPs in infected cells with low or no DVGs are efficiently packaged 
and released as standard virus or DPs. The differential interaction of virus and host 
proteins amongst infected cells in a population highlights the complexity and 
heterogeneity of viral infections. Most studies of the interactions of host proteins with 
viral components have relied on the purification or tagging of viral proteins or viral RNPs. 
However, we show that not all vRNPs across different cells within an infected population 
behave similarly, as DVG-high cells show differential distributions of viral components 
with distinct functional outcomes. The presence of DVGs within prepared viral stocks or 
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the accumulation of DVGs during an infection is near ubiquitous for viruses of the order 
Mononegavirales, orthomyxoviruses, and others (90, 91). Our results indicate that not 
only may DVGs shape the outcome of infection, but also the interaction of viral genomes 
with the intracellular trafficking machinery.  
DVGs are important modulators of pathogenesis in many, but perhaps not all, 
infections as they ameliorate disease courses through the induction of antiviral immunity, 
particularly in paramyxovirus infections (140, 141). Additionally, DVG-high cells induce 
pro-survival pathways that extend their life span and facilitate the establishment of viral 
persistence (165). The differential distribution of DVGs within cells and their failure to 
form large perinuclear clusters, may be a clue to some of the functions that DVGs carry 
out in driving immunity and stimulating pro-survival pathways. Clustering of viral RNA 
into specialized structures in order to evade viral RNA sensing by RLRs has been 
described for a number of viruses including those of the paramyxovirus family (44). 
Though this specific proviral function has not been described for Sendai virus, the 
differential localization of DVGs and their correlation with immune stimulation may offer 
an additional explanation for why these viral products so actively engage with RLRs.  
A widely described impact of DVGs on virus production is their ability to strongly 
interfere with viral protein expression and consequently broadly lower levels of standard 
virus replication and virion production (156, 189). However, our data indicate that the 
presence of defective particles in an infection led to a reduction in the proportion of cells 
able to produce virus rather than a global lowering of virus production in all cells and 
indicates the importance of moving away from bulk population analysis when studying 
the impact of DVGs on an infection. We show that the presence of high levels of DVGs 
within infected cells drastically limits the production of virions by such cell, and the 
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mechanisms leading to this reduction in virion production are of interest. Our data 
indicates that the immunostimulatory nature of DVGs does not impact these differences 
(Fig 2.9), and we presume that interference leading to reduction in certain viral proteins 
may play a role. Interestingly, when analyzed on a per cell basis, levels of NP do not 
decrease significantly with the accumulation of DVGs within cells, suggesting that not all 
viral proteins are subject to stark interference. However, as NP is the first and most 
abundantly produced mRNA and protein, there may be additional interfering affects on 
subsequent proteins, which may influence viral particle assembly and production. While 
DVG-high cells do have decreased levels of HN on the surface, we confirmed that this 
level of HN is also found in a subpopulation of DVG-low cells that produces virions at 
normal rates. These data suggest that the defect of DVG-high cells in producing DPs 
cannot be explained by a reduction in the amount of HN. However, it is possible that 
reductions in the amount of other proteins implicated in particle production may play a 
role. For example, matrix protein bridges the interactions between viral glycoproteins, 
including HN, and vRNPs, yet the details of how it functions in particle assembly are 
unknown. Evidence indicates that matrix traffics to the cell surface together with viral 
glycoproteins but independently of vRNPs (190) while other evidence suggests that 
matrix interacts with cytoplasmic vRNPs and is critical for vRNP transport to the cell 
membrane (191, 192). Regardless of how matrix works, high levels of DVGs during 
infection can destabilizes matrix leading to failure of virus assembly (155). Whether 
matrix interacts with recycling endosomes or facilitates recycling endosome interactions 
with vRNPs is unknown. Our data suggest that defects in particle assembly in DVG-high 
cells may originate prior to their assembly at the cell membrane, as we fail to see 
interaction of DVGs with Rab11a and microtubules required for the trafficking of vRNPs 
to the plasma membrane. It is possible that matrix plays an important role in these 
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interactions. Analysis of RNA from sorted cells shows that DVG-high cells contain lower 
levels of SeV M mRNA transcripts compared to FL-high cells, as expected. However, 
they do express SeV M mRNA and it is unclear how these lower levels impact protein 
amounts and whether this is a meaningfully lower level of viral protein. Unfortunately, 
due to limitations in tools available to study SeV M protein, we are currently unable to 
address these questions. Additionally, the non-structural viral protein C has been 
implicated in the formation of viral particles through mechanisms that remain 
controversial, and C protein is subject to additional regulations at a transcriptional level 
which may be altered in DVG-high cells (59, 69, 70). Further investigation into why DVG 
high cells fail to engage with these pathways should provide important insight into 
mechanisms mediating viral genome trafficking and egress, and possibly reveal 
additional roles of matrix or C protein in regulating virion formation. 
The production of DPs and the transmission of DVGs during an infection can 
have large impacts on the infection outcome in cells (165), in animals (140, 141), and in 
humans (107). Here we show that cells accumulating the majority of DVGs during an 
infection are not the main producers of DPs. Rather, DPs and virus are produced from 
FL-high cells. Notably, FL-high cells die more promptly during infection (165) raising 
intriguing questions about the dynamics of virus spread and pathogenesis. The presence 
of DVG-high cells during infection occurs in the presence of high levels of DPs, however 
during natural infections there may be low levels of transmission of DPs. Therefore, a 
natural infection would presumably originally begin as low-DVG. Once DVGs 
accumulated in an LD infection (Fig 2.1H), the production of DPs as well as standard 
virus could lead to a local area of high-DVG infection and produce DVG-high cells, which 
would then be capable of triggering antiviral immunity. The production of DVGs in vivo 
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has been established (140) and modeling of DVGs during transmission has been 
attempted (174, 193), but we believe that our updated model could yield more insights in 
to these infection dynamics.  Additionally, the ability to separate and distinguish 
defective genomes from FL genomes has allowed us to further characterize properties of 
the viral genomes during an infection and reveal that cells enriched in DVGs do not 
engage with microtubules/Rab11a-driven viral production pathways. This dichotomy 
within a single population is a useful tool not only to understand the immunostimulatory 
functions of DVGs in infections, but also allows us to further investigate additional 
fundamental aspects of paramyxovirus biology.  
2.6 Materials and Methods 
Cells and Viruses 
A549 cells (human type II pneumocytes, ATCC CCL-185) and LLCMK-2 (monkey kidney 
epithelial cells, ATTC CCL-7) were cultured in Tissue Culture Medium (DMEM 
(Invitrogen) supplemented with 10% Fetal Bovine Serum (Serum Source International), 
Gentamicin (ThermoFisher), Sodium Pyruvate (Invitrogen), L-glutamine (Invitrogen)) at 
7% CO2, 37°C. Generation of A549 CRISPR cell lines is described in (8). Cells were 
treated with Mycoplasma Removal Agent (MP Biomedical) upon thawing and tested 
monthly for mycoplasma contamination using MycoAlert PLUS Mycoplasma testing kit 
(Lonza). Sendai Virus was grown in 8-day embryonated, specific pathogen free chicken 
eggs (Charles River) for 40 h before allantoic fluid was harvested. LD and HD stocks 
were produced as described previously (164). Viruses were characterized by ratio of 
TCID50 to direct HA. In brief, TCID50 was determined by 1:10 serial dilutions of virus in 
infection media (DMEM (Invitrogen) supplemented with 35% BSA (Sigma-Aldrich), 
Pen/Strep (Invitrogen), 5% NaHCO3 (Sigma-Aldrich)) prior to infection of LLCMK2 cells 
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for 72 h in the presence of 2 μg/mL TPCK trypsin (Worthington Biochemicals), followed 
by hemagglutination of 0.5% chicken red blood cells (Lampire) to determine presence of 
virus in the supernatant. Titers were calculated using the Reed and Muench method 
(194). Total hemagglutinating (HA) titers were obtained by testing 1:2 serial dilutions of 
the virus in PBS for hemagglutination of 0.5% chicken RBCs. TCID50/HA ratios were as 
follows: SeV Cantell LD = 195,776; SeV Cantell HD = 48,944; SeV 52 LD = 235,151; 
SeV 52 HD = 784.  Infections were performed at an MOI of 1.5 TCID50/cell with virus 
diluted in infection media. Cells were washed twice with PBS then incubated with 
infection media with virus at low volume at 37°C for 1 h. Cells were then supplemented 
with 2% FBS Tissue Culture Medium for indicated time periods. Defective Particles (DP) 
were purified from the allantoic fluid of SeV Cantell infected embryonated eggs by 
density ultracentrifugation on a 5-45% sucrose gradient, as previously described (140). 
Immunofluorescence 
Cells were seeded on No. 1.5 glass coverslips (Corning) prior to infection. At 
indicated time points, coverslips were briefly washed in PBS then fixed in 4% 
Paraformaldehyde (Electron Microscopy Sciences) for 10 min. Cells were 
permeabilized with 0.2% Triton-X (Sigma-Aldrich) for 10 min. Primary and 
secondary antibodies were diluted in 3% FBS/PBS and incubated at RT for 1.5 h 
and 1 h, respectively. Nuclei were stained with Hoechst for 10 min prior to 
mounting coverslips on slides using Fluoromount-G (ThermoFisher). Antibodies: 
SeV NP (clone M73/2 a kind gift from Alan Portner – directly conjugated with 
Dylight 594 NHS Ester (ThermoFisher)), Rab11a (Abcam, ab65200), alpha-
tubulin (Abcam, ab52866), GM130 (Abcam, ab52649), calnexin (Abcam, 
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ab133615), TOM20 (Santa Cruz, sc-11414), AlexaFluor 647 Phalloidin 
(Invitrogen, A22287), Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa 
Fluor 488 (Invitrogen, R37116)). 
RNA FISH 
Custom probe sets (described in Reference (165) and Table 1) conjugated to Quasar 
570 and Quasar 670 dyes were purchased from LGC Biosearch. Cells were seeded on 
No. 1.5 glass coverslips (Corning) prior to infection. At indicated time points, coverslips 
were briefly washed in PBS then fixed in 3.7% formaldehyde (ThermoFisher) for 10 min. 
Cells were permeabilized in 70% EtOH for 1 h, washed in wash buffer (2X SSC 
(ThermoFisher), 10% formamide (ThermoFisher) in nuclease free water), and then 
subjected to hybridization with FISH probes. In brief, probes were diluted to 2.5nM in 
hybridization buffer (wash buffer + dextran sulfate) and applied to slides. Slides were 
incubated with probe overnight at 37°C in a humidified chamber. Prior to imaging, slides 
were washed in wash buffer twice (once with Hoechst to stain nuclei) then 2X SSC. 
Cells were mounted in anti-fade buffer (2X SSC, 0.4% glucose (Sigma), Tris-HCL pH 8.0 
(USB Corporation) with Catalase (Sigma) and Glucose Oxidase (Sigma)) and sealed 
with rubber cement. RNA FISH combined with immunofluorescence includes the 
following modifications: after fixation with EtOH, cells are stained with antibody in 1% 
BSA (ThermoFisher) PBS with RnaseOUT (Invitrogen); 45 min for 1° Ab, 40 min for 2° 
Ab. Cells were then post-fixed for 10 min in 3.7% formaldehyde prior to hybridization.  
Microscopy and Image Analysis 
Widefield images were acquired on a Leica DM1000 microscope with 40X (1.25-0.75 
NA) and 63X (1.40-0.60 NA) oil-immersion objectives. Confocal images were acquired 
on a Leica SP5-II Laser Scanning Confocal with 63X (1.40-0.60 NA)  and 100X (1.46 
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NA) oil-immersion objectives with pixel size of 50.4nm x 50.4nm for immunofluorescence 
images and 120.2nm x 120.2 nm for FISH immunofluoresence. Images were 
deconvolved using Hugyens Essentials Deconvolution Wizard using theoretical point 
spread function and images were processed in Volocity  (Perkins-Elmer). Global 
Pearson’s Correlation was calculated in Volocity using automatic thresholding based on 
(195). For Rab11a/5’(-)SeV colocalization, non-specific nuclear staining was excluded 
using the Fiji software by subtracting signal from nuclear area defined by Hoechst 
staining.  For individual cell measurements ROIs were defined manually for Global 
Pearson’s Correlation. Measurements of nucleoprotein distribution and amount were 
done using MetaMorph (Molecular Devices) multiwavelength cell scoring application 
using phalloidin staining to define cellular boundaries.  Single plane images were used 
for quantification and plane was determined by phalloidin staining in order to avoid bias. 
RNA Extraction and PCR/RT-qPCR 
RNA was extracted from Trizol (Invitrogen). Cellular and viral mRNA was reverse-
transcribed using RNA-to-cDNA kit (Invitrogen). Viral RNA was reverse-transcribed 
using SuperScript III First Strand Synthesis System (Invitrogen) with primer 5’-
GGTGAGGAATCTATACGTTATAC-3’. PCR was performed using Platinum Taq DNA 
polymerase (Invitrogen) the reverse transcription primer and 5’-
ACCAGACAAGAGTTTAAGAGATATGTATT-3’. qPCR was performed with 1:40 dilution 
of cDNA, SYBR Green (Life Technologies) and 5uM forward/reverse primers (Invitrogen) 
on an Applied Biosystems ViiA 7 Real-Time System. Relative copy numbers per cell 
were calculated by delta-delta Ct and normalized to average cellular GAPDH expression 
levels. Primer sequences are: SeV NP (F: 5’-TGCCCTGGAAGATGAGTTAG-3’, R: 5’- 
GCCTGTTGGTTTGTGGTAAG-3’), gSeV (F: 5’-GACCAGGAAATAAAGAGTGCA-3’, R: 
58 
 
5’-CGATGTATTGGCATATAGCGT-3’), DVG-546 (F: 5’-
TCCAAGACTATCTTTATCTATGTCC -3’, R: 5’-GGTGAGGAATCTATACGTTATAC-3’), 
IFNB (F: 5’-GTCAGAGTGGAAATCCTAAG-3’, R: 5’-ACAGCATCTGCTGGTTGAAG-3’), 
IFIT1 (F: 5’- GGATTCTGTACAATACACTAGAAACCA-3’, R: 5’- 
CTTTTGGTTACTTTTCCCCTATCC-3’) 
siRNA  
Cells (3x104) were transfected with 75μM On-TARGET Plus SMARTpool Rab11a 
(Dharmacon GE), a mixture of four siRNA targeting Rab11a diluted in Opti-MEM, using 
Lipofectamine RNAiMAX (Invitrogen). Transfection was performed 72 h prior to infection 
to allow sufficient knockdown. Knockdown was assessed using immunofluorescence, 
RT-qPCR, and Western Blot to confirm protein and mRNA levels. Control cells were 
transfected with 75μM On-TARGET Plus non-targeting pool following identical 
procedures.  
Western Blot 
Cells were lysed in NP-40 lysis buffer (Amresco) with proteinase inhibitors (Roche 
Boehringer Mannheim), Rnase OUT (Invitrogen) and EDTA (ThermoFisher). Protein 
concentration was measured using BCA Protein Assay (ThermoFisher). Protein (10μg) 
was denatured by boiling for 10 min and loaded in a 10% Bis-Tris Gel (Bio-Rad) then 
transferred to PVDF membrane (Millipore). Membranes were incubated overnight with 
primary antibody in 5% milk (rabbit anti-Rab11a (Abcam) and mouse anti-GAPDH 
(Sigma)). Membrane was incubated with anti-rabbit HRP-conjugated antibody (Cell 
Signaling) or anti-mouse HRP-conjugated antibody (Jackson Immunologicals) in 5% milk 
and developed using Lumi-light western blot substrate (Roche) to detect HRP.   
Drug Treatment  
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Four h post infection, media was removed and replaced with 2% FBS tissue culture 
media containing 2μg/mL Nocodazole (Sigma-Aldrich) for duration of infection.  
Flow Cytometry 
Cells were stained with anti-4-1BB (Biolegend clone 4B4-1, #309819) and anti-SeV HN 
(Clone 6F11, kindly provided by T. Moran) followed by anti-IgG2a PE-/Cy7 (Biolegend 
clone RMG2a-62, #407113) at 24 h post infection. Cells were sorted on BD FACS Aria II 
SORP. Mock infected and SeV-LD infected cells were used to inform gating. Analysis 
was done using FlowJo_v9.9.4 (BD Biosciences). 
Viral Production Analysis 
Sorted cells (1.5x105 cells per population) were incubated for 30 min in 1% anti-SeV 
mouse serum twice to remove virus bound to the surface. Cells were then seeded in a 
24-well plate in Infection Media (described above) and cultured for 24 h. 24 h post 
culture, media was collected and analyzed for virus particles. Detection of DPs was 
performed by infecting LLCMK2 cells with an inoculum containing 100μl of culture 
supernatants with 100ul of infection media containing SeV 52-LD to reach an MOI of 1 
TCID50/cell and 2μg/mL TPCK Trypsin (Worthington) for 24 h.  
Statistics 
Statistics were calculated using GraphPad Prism 5 for Mac.  
Table 1. Probe sequences for SeV negative sense genome probes 
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CHAPTER 3: The Viral Polymerase Complex Mediates the 
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3. 1 Abstract 
Paramyxoviruses are negative sense single-stranded RNA viruses that comprise 
many important human and animal pathogens, including human parainfluenza viruses. 
These viruses bud from the plasma membrane of infected cells after the viral 
ribonucleoprotein complex (vRNP) is transported from the cytoplasm to the cell 
membrane via Rab11a marked recycling endosomes. The viral proteins that are critical 
for mediating this important initial step in viral assembly are unknown. Here we use the 
model paramyxovirus, Sendai virus (SeV), recently named murine parainfluenza virus 1, 
to investigate the roles of viral proteins in Rab11a-driven virion assembly. We previously 
reported that infection with SeV containing high levels of copy-back defective viral 
genomes (DVGs) generates heterogenous populations of cells, with cells enriched in 
full-length virus producing viral particles containing standard or defective viral genomes, 
while cells enriched in DVGs did not, despite high levels of defective viral genome 
replication. Here we take advantage of this heterogenous cell phenotype to identify 
proteins that mediate interaction of vRNPs with Rab11a. We examine the role of matrix 
protein and nucleoprotein and determine that they are not sufficient to drive interaction of 
vRNPs and recycling endosomes. Then, using a combination of mass spectrometry and 
comparative protein abundance and localization in DVG- and FL-high cells, we identify 
viral polymerase complex components L and, specifically, its cofactor C proteins as 
interactors with Rab11a. We find that accumulation of these proteins within the cell is the 
defining feature that differentiates cells that proceed to viral egress from cells which 





Paramyxoviruses are a family of viruses that include a number of pathogens with 
significant burdens on human health. Particularly, human parainfluenza viruses are an 
important cause of pneumonia and bronchiolitis in children and do not have any 
vaccines or direct acting antivirals. These cytoplasmic replicating viruses bud from the 
plasma membrane and coopt cellular endosomal recycling pathways to traffic viral 
ribonucleoprotein complexes from the cytoplasm to the membrane of infected cells, yet 
the viral proteins required for viral engagement with the recycling endosome pathway is 
not known. Here we use the model paramyxovirus Sendai virus, or murine parainfluenza 
virus 1, to investigate the role of viral proteins in this initial step in viral assembly. We 
find that viral polymerase components large protein L and accessory C proteins are 
necessary for engagement with recycling endosomes. These findings are important in 
identifying viral targets for the development of antivirals.  
4. 3 Introduction 
Paramyxoviruses, as well as orthomyxoviruses and hantaviruses, use the 
recycling endosome pathway as a controlled mechanism of egress to traffic vRNPs from 
the infected cell cytoplasm to the cell membrane(45). Rab11a, a host GTPase 
associated with recycling endosomes, is critical for the transport of cargo from early 
endosomes to the perinuclear endocytic recycling complex and back to the plasma 
membrane(196). Paramyxoviruses that rely on Rab11a for intracellular transport and 
viral egress include SeV(47), measles(50), mumps(49), and HPIV1(47). While it is 
known that the vRNP interacts with Rab11a, it is not known which viral proteins are 
necessary to drive this critical interaction required for viral particle assembly. In fact, 
while multiple proteins including M and C have been investigated for their role in driving 
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viral assembly, their roles remain contested and poorly understood (20). For example, 
SeV M has been reported to interact with vRNPs in the cytoplasm and be required for 
recruitment of vRNPs to the membrane (191, 192) but has also been shown to traffic 
with surface proteins F and HN via the trans-golgi network (190). Whether the M protein 
is critical for engagement of SeV vRNPs with Rab11a marked endosomes is unknown. 
Further, in addition to the C proteins’ roles in innate immune antagonism and 
polymerase function, they have also been reported to be enhancers of particle formation 
(68, 70). Data has suggested that C is critical in recruiting vRNPs to the membrane (70), 
and that C expression enhanced association of vRNPs to membranes. Additionally, both 
C and M proteins have been shown independently to recruit Aip1/Alix, a protein involved 
in endosomal sorting and vesicle budding, to the plasma membrane to enhance virion 
formation(67, 68). But the requirement for Aip1/Alix in paramyxovirus budding is 
contested with evidence that absence of Aip1/Alix in cells does not have any effect on 
SeV particle formation(69). Thus, while both C and M have been heavily studied in the 
context of particle assembly, a clear picture of how these proteins function in early steps 
of assembly is lacking.    
We previously reported that upon infection with DVG-containing virus 
populations, cells display a heterogenous phenotype with the development of 
subpopulations of DVG-high cells and full-length (FL)-high cells(165, 197). DVG-high 
cells contain higher levels of DVGs than full length genomes, and FL-high cells contain 
higher levels of full-length genomes than DVGs. Not only do these subpopulations have 
distinct transcriptional profiles(165), but they have different intracellular localizations of 
viral RNA(vRNA) (197). The vRNA in FL-high cells interacts with recycling endosomes 
and this leads to the production of both standard and defective viral particles, while the 
66 
 
vRNA in DVG-high cells does not interact with recycling endosomes and consequently 
these cells do not produce significant amounts of viral particles. However, these DVG-
high cells undergo robust levels of vRNA replication as evidenced by the large increase 
in DVG RNA by qPCR and vRNA fluorescent in situ hybridization (FISH) over time(165) 
(197). In this chapter, we take advantage of DVGs as a system to investigate early steps 
that differentiate viral replication from viral particle production, namely how vRNPs 
interact with Rab11a, and describe the viral polymerase components L and C as 
differentiating factors in FL-high cells that facilitate vRNP association with recycling 
endosomes and subsequent viral assembly.  
3.4 Results 
3.4.1 M protein interacts with NP primarily at the cell surface and does not localize with 
Rab11a  
 Though SeV matrix protein (M) is necessary for SeV particle assembly(20), 
whether it is required for the association of vRNPs to recycling endosomes is unknown. 
It has been proposed that M is targeted to the plasma membrane together with the F and 
HN proteins(190) and, conversely, to traffic with vRNPs from the cytoplasm to the 
plasma membrane(191). In order to investigate whether the M protein is responsible for 
the association of vRNPs with recycling endosomes, we created a recombinant SeV with 
an HA-tag on the N-terminus of the M protein (SeV-M-HA) to study its localization during 
infection. We characterized this virus to ensure that the HA-tag did not result in a 
dramatically different growth curve from the parental SeV F1R strain (SeV-F1R) and 
found that while viral output was slightly lower at later time points in infection, virion 
production was largely unimpaired (Fig. 3.1A). We then examined the localization of M 
during infection. Consistent with the fact that M lines the inside of virions and budding 
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occurs from the plasma membrane, we observed M at the plasma membrane of infected 
cells (Fig. 3.1B-D). Interestingly, single plane confocal images show little overlap of NP 
and M proteins (Fig. 3.1B).  
 As we previously reported, when Rab11a is knocked down by siRNA or when 
microtubule polymerization is disrupted, the perinuclear localization of viral RNA is 
altered(197). To ask if M interacted with the Rab11a/microtubule pathway, we assayed 
the localization of M upon treatment with nocodazole, a drug that prevents microtubule 
polymerization. In agreement with previously published data, nocodazole treatment of 
FL-high cells disrupted perinuclear clustering of the viral NP, indicating that vRNPs are 
tethered to microtubules via recycling endosomes(197). In contrast, M protein 
distribution was not drastically altered when cells were treated with nocodazole and it 
still localized at the plasma membrane (Fig. 3.1C). These data support a model whereby 
the M protein is trafficked to the cell plasma membrane independently of the microtubule 
network, implying that the M protein it is unlikely to be critical in driving interaction 
between vRNPs and recycling endosomes.   
 It has also been reported that DVGs lead to increased degradation and turnover 
of M(155). Therefore, if M is the protein responsible for tethering vRNPs to recycling 
endosomes, it is possible that DVGs in DVG-high cells fail to interact with Rab11a due to 
insufficient levels of M to drive this interaction. To address this possibility, we 
overexpressed M-FLAG in cells infected with SeV Cantell strain with a high level of 
DVGs (HD) which generates a heterogenous population of DVG-high and FL-high 
cells(165, 197) and asked whether high levels of M were sufficient to drive a perinuclear 
localization of DVGs. For these experiments we used 293T cells because they allow for 
infection and subsequent transfection of the same cell. We confirmed using vRNA FISH 
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to distinguish DVG from gSeV RNA (Fig. 3.1D) that the distinct intracellular distribution 
of FL-high and DVG-high cells was conserved in these cells. Overexpressed M localized 
to the membrane of infected cells, as expected. However, overexpression of M in DVG-
high cells failed to recruit DVGs to the perinuclear region with DVGs remaining 
distributed throughout the host cell cytoplasm (Fig. 3.1E). These data indicate that M is 
not sufficient to drive association between vRNPs and recycling endosomes.  
Finally, to confirm that M was not responsible for driving interactions between 
vRNPs and recycling endosomes, we infected A549 Rab11a-mcherry cells with SeV low 
DVG (LD) viruses, in which all vRNPs should interact with Rab11a(197), and performed 
immunofluorescence for various viral proteins (Fig. 3.2A) and compared their 
colocalization with Rab11a (Fig. 3.2B). As previously reported (197), in SeV LD 
infections NP and Rab11a colocalize in the perinuclear region. In contrast, M largely 
does not colocalize with Rab11a (Fig. 3.2B). We also examined the colocalization of 
Rab11a with other viral proteins, including the polymerase L and C proteins. We found 
that C also colocalizes with Rab11a to the same extent as NP, and that L colocalizes to 
an even higher degree than NP or C. This indicates that at this timepoint of infection, 
most or all L proteins are associated with recycling endosomes, while excess free NP 
and the pool of C proteins which antagonize innate immunity do not. Overall, these data 
support a model whereby vRNPs associate with Rab11a independent of M and likely 
through members of the polymerase complex L and C. In addition, our data support the 







Figure 3.1. Matrix protein localization to the plasma membrane occurs independently of 
microtubules/Rab11a. A) TCID50/mL of supernatant from LLCMK2 cells infected with SeV-M-
HA and SeV F1R (parental wildtype) at indicated timepoint, n = 3, graphed as mean ± SEM. B) 
A549 cells infected with SeV-M-HA for 24 hpi, immunofluorescence for SeV NP (red), HA (SeV 
M, green), Hoechst (nuclei, blue). Confocal 63x, 2x digital zoom. Panels 1-3 showing extended 
focus, panel 4 showing cropped single XY plane as well as XZ and YZ planes.  C) A549 cells 
infected with SeV-M-HA, treated with nocodazole or DMSO vehicle control at 4hpi, 
immunofluorescence at 24 hpi for SeV NP (red), HA (SeV M, green), Hoechst (nuclei, blue). 63x 
widefield deconvoluted, max projection shown.  D) Schematic of vRNA FISH to detect (-)gSeV 
and (-)DVG RNA, indicating red and green probe binding regions. E) 293T cells infected with SeV 
Cantell HD then transfected with SeV M-FLAG at 6hpi, vRNA FISH with immunofluorescence for 
FLAG (SeV M, gray) at 24hpi. 63x widefield deconvoluted, max projection shown. Magenta 
arrows indicate infected and transfected cells. All images are representative of 3 independent 
experiments, scale bar = 20µm. 
 
 
Figure 3.2. vRNP components colocalize with Rab11a but SeV M does not A) A549-Rab11-
mcherry cells infected with SeV M-HA (M and NP), SeV Cantell LD (C), or SeV LeGFP (L) for 24 
hours. Immunofluorescence for viral antigens (purple), mcherry-Rab11a shown in (green). 
Confocal 63x images, 1.5x zoom, max projection shown. All images are representative of 3 
independent experiments, scale bar = 20µm. B) Quantification of colocalization between viral 
proteins and Rab11a, pooled from three independent experiments with >20 cells analyzed per 
experiment. Individual cells are plotted with line at the mean and error bars represent SD. ****= 





3.4.2 Nucleoprotein coverage of vRNPs is not sufficient to drive interaction with Rab11a 
 Because we observed that NP, L, and C proteins all colocalized with Rab11a 
during infection, we next sought to address which of these proteins was important for the 
interaction of vRNPs with recycling endosomes. First, we asked whether NP was 
sufficient for driving this interaction. As the most abundant protein on the vRNP, it is 
possible that NP coverage of the viral genome dictates engagement with Rab11a. We 
reasoned that if NP coverage of vRNPs was critical for interaction with Rab11a, the lack 
of engagement of vRNPs with Rab11a in DVG-high cells may be explained by high 
levels of free or partially coated vRNA. In order to investigate whether viral RNA in DVG-
high cells was coated in NP we tested for colocalization of these NP and viral genomes 
using RNA FISH combined with immunofluorescence for NP (Fig. 3.3A). To confirm the 
association of NP with DVG RNA, we quantified colocalization of 5’(-)SeV RNA with SeV 
NP (Fig. 3.3B-D). As shown in (Fig. 3.1D) the 5’(-)SeV probe set binds to all species of 
negative sense vRNA in cells. In DVG-high cells, the majority of vRNA recognized by 5’(-
) SeV probe RNA corresponds to DVGs, but in FL-high cells it corresponds primarily to 
FL-genome RNA as indicated. We found that there was no significant difference in the 
colocalization between viral RNA and SeV NP in DVG-high and FL-high cells (Fig. 
3.3B). Mander's overlap coefficient (MOC) indicates the portion of a signal that overlaps 
with the other signal in question, regardless of signal intensity. The MOC for NP with 
viral RNA showed that nearly all NP in DVG-high cells overlapped with viral genomes, 
but a lower fraction of SeV NP overlapped with vRNA in FL-high cells, presumably due 
to excess free NP that is not coating viral genomes (Fig. 3.3C). The MOC for 5’(-)SeV 
RNA overlap with NP was equivalent between DVG-high and FL-high cells, indicating 




Figure 3.3. Nucleoprotein association is similar between full-length and defective viral 
genomes A) A549 cells infected with SeV Cantell HD for 24 hours and then subjected to RNA 
FISH with immunofluorescence for NP (gray), Hoechst (nuclei, blue). Confocal 63x image, 1.5x 
zoom, single plane image shown. Images are representative of three independent experiments, 
scale bar = 20µm.  B) Costes’s Pearson’s correlation of colocalization between (-)5’SeV and SeV 
NP in individual DVG-high and FL-high cells. C) Mander’s overlap coefficient of NP with 5’ SeV in 
DVG-high and FL-high cells D) Mander’s overlap coefficient of 5’SeV with NP in DVG-high and 
FL-high cells. Individual cells pooled from three independent experiments are plotted with line at 
the mean and error bars representing SD. **** = p<0.0001 by Mann-Whitney U-test. E) CT values 
for qPCR for viral RNA, DVG RNA, and GAPDH with and without RNase A, V1, and T1 treatment 
after immunoprecipitation with anti-SeV NP. F) Fold change in RNA levels in RNase treated 
immunoprecipitation products relative to untreated. Data from four independent experiment are 




Though DVGs appear to be associated with NP, we wondered whether NP 
coating of DVGs was complete. We reasoned that there may be regions of exposed 
RNA that may disrupt the helical structure of the vRNP and therefore prevent 
interactions with host factors. To assess the integrity of the vRNP we performed an 
immunoprecipitation (IP) of NP from infected cells and subjected the IP product to 
RNase digestion with a combination of RNase A, V, and T1, targeting both single and 
double stranded RNA. RNA was then extracted and analyzed by RT-qPCR to compare 
levels of viral RNA to untreated controls. There was no significant difference in RNA 
quantities between DVG RNA and full-length vRNA in treated and untreated conditions 
(Fig. 3.3E). We also tested unbound fractions of the pulldown, reasoning that if there 
was any free RNA it would not be precipitated by anti-NP antibody. Both vRNA and DVG 
RNA where found in the unbound fraction indicating that the IP did not precipitate all of 
the vRNPs, but the RNA in this fraction was also not significantly different between 
treated and untreated conditions, particularly in comparison to an abundant cellular 
mRNA, GAPDH (Fig. 3.3F). These data do not preclude that there is some degree of 
uncoated RNA in DVG-high cells, but it indicates that the vast majority of vRNPs present 
during high DVG infections are sufficiently coated in NP. These data indicate that while 
NP and the vRNP associate with Rab11a in FL-high cells, NP coating of viral genomes 
is not sufficient to drive association with recycling endosomes and is likely not providing 
a direct link between viral genomes and Rab11a.   
3.4.3 DVG driven interference leads to strong decrease in L transcripts and protein 
 Accumulation of DVGs leads to a decrease in standard viral genome replication 
and viral protein accumulation, a phenomenon known as interference. This interference 
is due to DVGs competing for viral polymerase and other proteins necessary for viral  
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replication (159, 175). In order to take a more systematic approach to the examination of 
the role of viral proteins in viral assembly, we investigated whether the interference 
effect resulting from high levels of DVGs had an equal impact across viral proteins or 
whether there were certain viral mRNAs and proteins most drastically impacted by 
interference. The hypothesis was that those proteins most interfered with by DVGs are 
essential for the localization of vRNPs to recycling endosomes and in their absence 
vRNPs, including DVG vRNPs, mislocalize within the cytoplasm. 
The transcription of paramyxovirus mRNA is directed by the RdRP beginning at 
the 3’ end of the genome and progressively losing processivity to generate a gradient of 
mRNA, with highest levels of the 3’ proximal genes and lowest levels of the 5’ genes(14, 
27) produced (Fig. 3.4A). To determine whether interference with mRNA transcription by 
DVGs had a more drastic effect on some viral mRNAs compared to others, we 
performed qPCR on viral RNA from SeV LD and HD infected cell populations at 12 
hours post infection, the time at which there is the highest rate of mRNA accumulation 
compared to genome accumulation(31, 197). As expected, we observed a gradient of 
transcription with higher levels of the 3’ proximal transcripts and lowest amounts of L 
mRNA. Additionally, SeV HD infections had lower levels of viral mRNA levels across all 
genes (Fig. 3.4B). However, when comparing the levels of each mRNA across infections 
to normalize for differences in mRNA levels, it became clear that the levels of L mRNA 
were most significantly decreased (Fig. 3.4C). Because the SeV HD infections includes 
both FL-high and DVG-high cells, it is likely that levels of mRNA in DVG-high cells were 
even further reduced compared to levels of viral mRNA in LD infections, which contains 




Figure 3.4 L mRNA and protein is significantly reduced in DVG-high cells compared 
to other viral proteins A) Schematic of gene organization and gradient mRNA 
transcription in SeV. (B) A549 cells infected with SeV Cantell LD and SeV Cantell HD for 
12 hours, qPCR for viral genes shown as relative copy number compared to GAPDH and 
(C) relative amount in SeV HD infections compared to SeV LD infection for each viral gene. 
** = p< 0.01, * = p<0.05 by One-way ANOVA with Sidak’s multiple comparisons test. (D-F) 
A549 cells infected with SeV Cantell LD and SeV Cantell HD for 24 hours were subjected 
to RNA FISH combined with antibody staining for flow cytometry. (D) Representative flow 
plots for each condition with gates for DVG-high cells highlighted in green, and FL-high 
cells highlighted in red, and cells below limit of detection for viral RNA by flow in blue. (E) 
Representative MFI plot showing MFI of viral proteins in different cell populations in HD 
infected cells with FL-high cells shown in red and DVG-high cells shown in green, mock 
cells shown with dashed line. (F) relative MFI in DVG-high cells compared to FL-high cells 
in SeV HD infected conditions, four independent experiments are shown with bars 
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To determine whether decreases in viral mRNA transcription translate to lower 
levels of viral protein, we quantified protein levels in DVG-high and FL-high cells. SeV 
HD infections were subjected to RNA FISH flow coupled with immunostaining for 
different viral proteins. RNA FISH-flow cytometry allows for the identification of discrete 
cell populations based on intensity of 3’- and 5’- SeV probes in each cell, using the same 
strategy as in imaging (Fig. 3.1D).  Using this method we are able to define DVG-high 
and FL-high populations (Fig. 3.4D) as validated in(165). We then calculated the mean 
fluorescence intensity as a proxy for viral protein amount in each of the identified 
populations (Fig. 3.4E). Levels of protein in DVG-high cells was normalized to FL-high 
cell levels (Fig. 3.4F). Levels of all viral proteins were lower in DVG-high cells compared 
to FL-high cells, recapitulating the mRNA data. These data show that the proteins that 
are the least abundant are most sensitive to DVG mediated interference as there is a 
much greater reduction of L protein in DVG-high cells than other viral proteins (Fig. 
3.4F). This observation suggests that the L protein may be an important factor in 
regulating interactions of vRNPs with recycling endosomes, as this is the most strongly 
differentiating factor between DVG-high and FL-high cells.  
3.4.4 SeV C proteins interact with Rab11a 
 We next used an unbiased approach to determine which viral proteins interact 
with Rab11a. To do this, we infected Rab11a-GFP A549 cells with SeV LD followed by 
immunoprecipitation (IP) of Rab11a using antibodies against GFP at 12 and 24 hours 
post infection to identify interacting proteins. By using SeV LD virus stocks we ensure 
that all cells are have vRNPs that are interacting with Rab11a. We also performed mass 
spectrometry on whole cell lysates. At 12 hours post infection, we identified viral proteins 




present in a gradient of abundance with highest levels of NP and lowest levels of L and 
accessory proteins C and V (Fig. 3.5A) recapitulating the gradient of viral mRNA 
observed in (Fig. 3.4B). We identified high levels of NP, M, and C proteins in the 
Rab11a IP (Fig. 3.5B).  C proteins are the most highly enriched viral proteins when 
normalized to levels of viral protein found in whole cell lysates (Fig. 3.5C), which was 
done to differentiate proteins that were enriched due to interactions with Rab11a from 
proteins simply increasing in abundance after viral infection. Similar results are observed 
at 24 hours post infection, with the magnitude of viral proteins increasing overall but 
trends staying the same (Fig. 3.5D-F).  We also compared the log fold change of 
proteins identified by IP at both 12 hours post infection (Fig. 3.5G) and 24 hours post 
infection (Fig. 3.5H) and identified the C proteins as the most significantly enriched viral 
protein interacting with Rab11a compared to mock at both time points. Additionally, L 
protein is identified as significantly enriched at 24 hours post infection. To validate these 
results, we performed a western blot and probed for Rab11a and various viral proteins 
(Fig. 3.5I). As expected, Rab11a was enriched after IP, while the viral protein P was not 
seen, corresponding with its absence in the mass spectrometry analysis. C protein has 
the highest ratio of IP to input, strongly suggesting that the C protein most directly 
interacts with Rab11a. Both NP and M proteins are moderately present in the IP and 
likely represent high levels of protein in the cell (NP) and potential interactions between 
Rab11a and M which may occur at the plasma membrane in late stages of particle 
formation as shown in Figure 1. Because SeV generates 4 C proteins that are described 
to have discrete functions(198), we asked whether we could identify which C protein was 
interacting with Rab11a. The four C proteins range in size from 175 to 215 amino acids 




Figure 3.5. C proteins identified to interact with Rab11a by immunoprecipitation and mass 
spectrometry A) Normalized protein abundance for viral proteins identified by mass 
spectrometry at 12 hpi. B) Normalized protein abundance of viral proteins identified by IP of 
Rab11-GFP at 12 hpi. C) Relative protein abundance of proteins identified by IP to total protein 
abundance in whole cell lysates at 12hpi. D) Normalized protein abundance for viral proteins 
identified by mass spectrometry at 12 hpi. E) Normalized protein abundance of viral proteins 
identified by IP of Rab11-GFP at 12 hpi. F) Relative protein abundance of proteins identified by IP 
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identified by in the IP by mass spectrometry to the C proteins (Fig. 3.5J) and found they 
were all from the shared 175 amino acid region, and therefore we could not conclude 
which specific protein(s) were identified. Overall, the identification of C proteins as a 
likely interactor of Rab11a by immunoprecipitation and subsequent mass spectrometry 
recapitulate results showing high degrees of colocalization as shown in (Fig. 3.2A-B) 
and suggests C proteins play an important role in directing interaction of vRNPs with 
recycling endosomes.     
3.4.5 Occupancy of polymerase proteins on viral genomes is the differentiating factor in 
vRNPs that interact or fail to interact with Rab11a  
 Because we found that the L protein was lowest in DVG-high cells when 
comparing DVG-high and FL-high cells and identified its cofactor C by mass 
spectrometry as a Rab11a interacting partner, we considered whether differences in 
polymerase component levels may drive differences in engagement with Rab11a in 
DVG-high and FL-high cells. To ask whether polymerase was associated with viral RNA 
in DVG-high cells we performed RNA FISH combined with immunofluorescence. To 
visualize L we used a recombinant SeV with C-terminus fused GFP (SeV LeGFP) that 
has been previously described(48) and the addition of purified defective particles 
containing DVG-546, the dominant DVG in SeV Cantell. Previous studies have validated 
the ability of other strains of SeV to replicate DVGs from heterologous strains(197). 
to total protein abundance in whole cell lysates at 12hpi. A-F, three independent experiments are 
plotted with bar representing mean, error bar representing SD.  G) Volcano plot comparing mock 
to 12 hpi and normalized to input or total abundance H) and comparing mock to 24 hours post 
infection and normalized to input. Data is pooled from three independent experiments. Viral 
proteins are indicated. Dark blue dots represent p>0.05 and light blue dots represent p<0.05 by 
student’s t-test. I) Validation of mass spectrometry by western blot probing for Rab11a or viral 
proteins at 24 hours post infection and quantified for relative band intensity of IP over input. J) 
Schematic of C proteins with locations of peptides identified by mass spectrometry in IP samples 




During infection with SeV LeGFP in the presence of purified defective particles (pDPs), 
we see the establishment of DVG-high cells, and strikingly these cells have very low 
levels of L protein (Fig. 3.6A), recapitulating flow cytometry results that showed large 
differences in the amount of L protein in DVG- and FL-high cells. Additionally, it appears 
that a majority of DVG RNA in DVG-high cells is not bound by L protein. Indeed, 
colocalization of 5’(-)SeV RNA and L was significantly lower in DVG-high cells compare 
to FL-high cells (Fig. 3.6B). The MOC of L is equivalent in DVG-high and FL-high cells, 
indicating that the same proportion of L in each cell is interacting with vRNA, indicating 
that the small amount of polymerase present in those cells is colocalized with DVG RNA 
(Fig. 3.6C). However, the MOC of 5’ (-) SeV RNA with SeV L was significantly lower in 
DVG-high cells compared to FL-high cells, indicating that a smaller fraction of viral RNA 
overlaps with L in DVG-high cells than in FL-high cells and that there are many DVG 
RNAs that are not occupied by a polymerase in DVG-high cells (Fig. 3.6D).  The small 
amount of L protein in DVG-high cells is likely associated with DVGs for replication, but 
the majority of DVGs within the cytoplasm of DVG-high cells are not associated with L. 
This strong difference in L interaction with viral RNA in DVG-high and FL-high cells 
indicates that L protein may be critical in driving vRNPs to interact with Rab11a. 
As levels of and engagement with the polymerase seems to be a differentiating 
factor between DVG-high and FL-high cells, we sought to investigate whether these 
differences were found with C protein as well.  Upon RNA FISH combined with 
immunofluorescence for C protein, we observed similar results to those seen with SeV L, 
with low levels of C protein in DVG-high cells and a perinuclear localization of C protein 
in FL-high cells (Fig. 7A), indicating indeed that at later timepoints of infection, C protein  
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associates with vRNA and presumably L. Quantification of colocalization revealed that 
there is a significantly greater degree of colocalization of C and 5’(-)SeV RNA in FL-high 
cells compared to DVG-high cells, indicating that like with L protein, many DVG vRNPs 
are not occupied by C protein (Fig. 7B). MOC of SeV C reveals that higher proportions 
of C are colocalized with 5’ (-) SeV RNA in DVG-high cells than in FL-high cells (Fig. 
7C). However, MOC of 5’ (-) SeV RNA with SeV C indicates that in FL-high cells, a high 
proportion of vRNA overlaps with C, while in DVG-high cells, much of the vRNA does not 
 
Figure 3.6. L protein interaction with vRNP distinguishes between DVG-high and FL-high 
cells A) A549 cells infected with SeV LeGFP supplemented with purified DPs (HAU 20) for 24 
hours and then subjected to RNA FISH with immunofluorescence for GFP (L, gray), Hoechst 
(nuclei, blue). Confocal 63x image, 1.5x zoom, single plane image shown. Images are 
representative of four independent experiments, scale bar = 20µm. B) Costes’s Pearson’s 
correlation of colocalization between (-)5’SeV and SeV NP in individual DVG-high and FL-high 
cells. C) Mander’s overlap coefficient of L (GFP) with 5’ SeV in DVG-high and FL-high cells D) 
Mander’s overlap coefficient of 5’SeV with L (GFP) in DVG-high and FL-high cells. Individual cells 
pooled from three independent experiments are plotted with line at the mean and error bars 




overlap with C proteins (Fig. 7D). These data indicate, that similarly to L protein, low 
levels of C proteins in DVG-high cells seem to colocalize with DVG-RNA but that very 
low levels of C protein in the cell leave many RNAs unbound by these proteins. Taken 
together, these data suggest that lack of accumulation of C and L proteins in DVG-high 
cells and therefore lack of C and L proteins bound to vRNPs precludes these vRNPs 
from interacting with Rab11a.  
 
 
Figure 3.7. C protein interaction with vRNP distinguishes between DVG-high and FL-high 
cells A) A549 cells infected with SeV Cantell for 24 hours and then subjected to RNA FISH with 
immunofluorescence for C (gray), Hoechst (nuclei, blue). Confocal 63x image, 1.5x zoom, single 
plane image shown. Images are representative of four independent experiments, scale bar = 
20µm.  B) Costes’s Pearson’s correlation of colocalization between (-)5’SeV and SeV C in 
individual DVG-high and FL-high cells. C) Mander’s overlap coefficient of C with 5’ SeV in DVG-
high and FL-high cells D) Mander’s overlap coefficient of 5’SeV with C in DVG-high and FL-high 
cells. Individual cells pooled from two independent experiments are plotted with line at the mean 
and error bars representing SD **** = p<0.0001 by Mann-Whitney U-test. 
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3.5 Discussion  
 We propose a model of Sendai virus assembly in which polymerase components 
including the viral polymerase L and its cofactor C are critical for the interaction between 
viral RNPs and Rab11a, a crucial initial step in viral particle production. In taking 
advantage of the difference in viral particle production in DVG-high and FL-high cells we 
parsed viral components that are critical for replication and those that are critical for viral 
assembly. DVG-high cells are able to carry out robust levels of viral genome replication 
using limited amounts of L but are unable to produce virions because they do not 
engage with host proteins critical for this process(197). We observed that DVG 
interference with viral protein expression critically diminishes levels of the viral 
polymerase L in DVG-high cells and we propose that L/C accumulation above a certain 
threshold is required for interaction of the vRNP with recycling endosomes and the 
cellular trafficking machinery. Further, we identified the C proteins as the most highly 
enriched viral proteins interacting with Rab11a by mass spectrometry. From these data 
we propose that recycling endosomes interacts with C proteins when it is bound to L, 
and that C-L polymerase complexes interact with vRNPs to tether then to recycling 
endosomes (Fig. 3.8).  
It remains to be determined whether paramyxoviruses interact directly with 
recycling endosomes via endosomal membrane interactions, with the Rab11a GTPase 
itself, with family-interacting proteins (FIPs) associated with Rab11a or via another 
mechanism. The different Rab11-FIPs direct engagement of Rab11a-marked recycling 
endosomes with dynein or myosin Vb motor proteins, and specific FIPs have been 
identified as important for budding of different viruses. For example Rab11-FIP2 is 
important for respiratory syncytial virus budding(53) and influenza relies on Rab11-FIP3 
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for filamentous particle production(52). The Rab11a-FIPs used for trafficking of SeV are 
unknown and identifying a viral protein that mediates interaction with recycling  
endosomes will aid further study of these dynamics. 
Negative-sense RNA viruses require packaging of RdRPs within virions to initiate 
infection. Indeed, SeV L proteins have been shown to associate with viral nucleocapsids 
isolated from virions(199). Additionally, C proteins have been found to be tightly 
associated with nucleocapsid structures both inside the cell as well as when isolated 
from SeV virions, with approximately 40 C proteins per vRNP(200). The observed role of 
polymerase components in assembly are in accordance with what was observed in 
infections with the orthomyxovirus influenza, where influenza virus RNPs interact with 
 
Figure 3.8. Model of SeV vRNP interaction with Rab11a. Viral replication occurs in the 
cytoplasm and upon accumulation of sufficient levels of L and C proteins, vRNPs interact 
with Rab11a-marked recycling endosomes via C and L proteins, in order to be trafficked to 
the plasma membrane.  
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Rab11a via one of its polymerase components PB2(201, 202). Like has been suggested 
for influenza, having the polymerase complex initiate packaging via interactions with 
Rab11a could be a mechanism to ensure that only vRNPs that contain a RdRP, and are 
thus infectious, can be packaged into virions.  
Most paramyxoviruses encode a number of accessory proteins off of the P gene, 
either through RNA editing leading to interferon antagonist V and W families, or by 
translating alternate reading frames from the P mRNA(74) to generate C family 
members. While we propose that C proteins are critical for engagement with Rab11a, we 
believe that in the absence of accumulation of sufficient L protein, vRNPs would be 
unable to interact with Rab11a.Thus, even if, for example, levels of C protein were 
higher in DVG-high cells, we would not expect to see C interacting with vRNPs in the 
absence of L. Additionally, the specific mechanisms that dictate translation of the C 
proteins (C, C’, Y1 and Y2) from the P mRNA are unknown. Therefore, how DVG-
mediated interference affects C protein accumulation is unclear. Further, while the C 
proteins have been described to have discrete functions in regulating pathogenesis and 
mRNA and vRNA synthesis(198), our results are unable to distinguish if a specific C 
protein is required for interaction with Rab11a or if they are interchangeable. The 
specific C proteins required for SeV assembly, and whether C family proteins of other 
paramyxoviruses play similar or distinct roles in viral assembly are as of yet unknown. 
Discerning their function in assembly could provide specific targets for the development 
of direct acting antivirals.   
 We also investigated the role of SeV M in viral assembly. M lines the inside of 
virions and interacts directly with nucleoproteins(192, 203). These contacts between M 
and the nucleoproteins drive virus-specific viral particle production, as studies combining 
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M and nucleoproteins from the closely related SeV and HPIV1 fail to lead to particle 
production(58). While M-NP contacts are important for particle production, it is unknown 
whether M is delivered to the cell membrane with nucleoproteins or independently, and 
whether its transport relies on Rab11a (20). Our experiments indicate that M is 
independently trafficked to the plasma membrane and is not the key mediator in vRNP 
interactions with Rab11a. Our data is consistent with previous reports that indicate that 
M traffics with F and HN through the trans-golgi network (TGN) to the cell 
membrane(190). We also identify M in the Rab11a IP-mass spectrometry results. 
Though we don’t see strong enrichment of M in the IP when validated by western blot, it 
is possible that interactions with Rab11a are occurring at the plasma membrane. 
Alternatively, if M is trafficked to the membrane with surface proteins F and HN as 
proposed by (190), Rab11a may be interacting with M near the TGN. There is evidence 
that the rhabdovirus vesicular stomatitis virus (VSV) glycoprotein, which is processed in 
the TGN, requires Rab11a for proper sorting to the plasma membrane(204). Therefore, it 
is possible that SeV M, F, and HN may interact with Rab11a during their transit from the 
TGN to the plasma membrane.  
 It is well established that DVGs exert effects on viral infections through interfering 
with standard viral genomes by competing for structural proteins or viral polymerase(92). 
DVGs have been reported to globally lower levels of viral proteins within infected cells 
and for that reason have been investigated as antivirals themselves(114). Whether all 
viral proteins are equally affected by interference has not been previously reported. 
While it has been shown that infections with SeV HD leads to lower levels of M protein, 
these lower levels were attributed to increased degradation of M(155). Presence of 
DVGs have also been shown to lead to lower levels of HN on the surface of infected 
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cells(156). We performed a systematic investigation of the effects of interference on 
levels of mRNA and protein levels by directly comparing FL-high cells and DVG-high 
cells from a heterogenous infection. Our results support previous finding of lower levels 
of M and HN in the presence of DVGs but reveal that DVG interference with L mRNA 
transcription leads to significantly lower amount of mRNA and subsequent lower protein 
translation in DVG-high cells. Because L is the lowest abundance mRNA and protein, 
DVG-driven interference has the highest impact on its abundance. The gradient 
expression of mRNA as well as copy-back DVGs are unique to single-stranded negative 
sense RNA viruses. However, other RNA viruses, such as influenza produce deletion 
DVGs and are known to be sensitive to DVG-driven interference. It has been shown that 
DVGs generated from certain segments can exert different levels of interference 
pressure(205), but not whether interference particularly affects the accumulation of 
certain mRNAs or proteins. The role that DVG-mediated interference may play in 
restricting viral progeny production via reduction of certain key proteins in other viral 
families remains to be investigated.  
Overall, we have shown that polymerase cofactors may be critical in inducing 
primary steps of viral assembly using DVGs as a tool to understand differences in viral 
replication and viral assembly. While we propose that C and L proteins are essential for 
driving contact between vRNPs and Rab11a during SeV infection, whether intricacies of 
viral assembly are conserved across paramyxoviruses is unknown. Many studies 
suggest that there are at least subtle differences amongst the viruses in their intracellular 
localization, transport, and eventual assembly(20). Because DVGs have been identified 
from most paramyxoviruses, comparisons between DVG-high and FL-high cells during 
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infection may be useful in parsing proteins required for viral replication from those 
required to initiate virion assembly of other members of the viral family.   
3.6 Materials and Methods 
Cells 
A549 (human type II pneumocytes, ATCC CCL-185) and LLCMK-2 (monkey kidney 
epithelial cells, ATTC CCL-7) were maintained in Tissue Culture Medium (DMEM 
(Invitrogen) supplemented with 10% Fetal Bovine Serum (Sigma), Gentamicin 
(ThermoFisher), Sodium Pyruvate (Invitrogen), L-glutamine (Invitrogen)) at 7% CO2, 
37°C. A549 Rab11-GFP and A549 Rab11-mCherry cells were generated as described in 
(202). Cells were tested monthly for mycoplasma MycoAlert Mycoplasma detection kit 
(Lonza) and treated with Mycoplasma Removal Agent (MP Biomedical) upon thawing.   
Viruses 
Sendai virus Cantell was grown in 10-day embryonated specific pathogen free chicken 
eggs (Charles River) for 40 hours before allantoic fluid was collected. Low DVG and high 
DVG stocks were produced as previously described, and defective particles (pDPs) were 
purified from allantoic fluid infected with SeV Cantell by density ultracentrifugation on a 
5-45% sucrose gradient. SeV-LeGFP is a recombinant Enders strain of virus described 
in(48). SeV-LeGFP cells was grown for 72 hours in LLCMK2 cells. SeV-M-HA virus was 
generated with an HA tag at the N-terminus of the M protein in a recombinant SeV F1R 
background. Virus was rescued by transfection in to BSRT7 cells as described(206) and 
passaged blindly three times. Virus was then grown for 5 days in LLCMK2 cells. All 
viruses were titrated using 1:10 serial dilution in triplicate in LLCMK2 cells in the 
presence of 2ug/mL TPCK trypsin (Worthington Biomedical) for 72 hours and TCID50/mL 
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was determined by the Reed-Meunch method based on hemagluttination of 0.5% 
washed chicken red blood cells (Lampire) to indicate presence of infection. 
Plasmids and Transfection 
SeV-M-FLAG plasmid encodes codon optimized SeV Matrix with a 3X N-terminal FLAG 
tag in the pCMV-3Tag-1A vector. Cells in antibiotic free media (8x105/6-well) were 
transfected 6 hours post infection with 2ug plasmid and 6ul Lipofectamine 2000 
(Invitrogen) per well diluted in Opti-MEM (Invitrogen).  
Viral Infections  
Infections were performed at a multiplicity of infection of 1.5 TCID50/cell unless otherwise 
specified. Cells were seeded to reach 80% confluency upon day of infection (4x105 
A549/well in 6 well plates). Prior to infection cells were washed twice with PBS. Virus 
was diluted in infection media (DMEM (Invitrogen) supplemented with 35% BSA (Sigma-
Aldrich), Pen/Strep (Invitrogen), 5% NaHCO3 (Sigma-Aldrich) and low volume inoculum 
was added to cells for 1 hour incubation at 37°C, with shaking every 15 minutes. Cells 
were then refed with 2% FBS Tissue Culture Medium.  
Drug Treatment  
Four h post infection, media was removed and replaced with 2% FBS tissue culture 
media containing 2μg/mL Nocodazole (Sigma-Aldrich) for duration of infection.  
Immunofluorescence 
Cells were seeded on No. 1.5 glass coverslips (Corning) overnight prior to infection. Post 
infection coverslips were rinsed in PBS then fixed for 10 minutes in 4% 
Paraformaldehyde in PBS (Electron Microscopy Sciences) for 10 min. Cells were 
permeabilized with 0.2% Triton-X in PBS (Sigma-Aldrich) for 10 min. Primary and 
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secondary antibodies were diluted in 3% FBS in PBS and incubated at RT for 1.5 h and 
1 h, respectively. Nuclei were stained with Hoechst  prior to mounting coverslips on 
slides using Fluoromount-G (ThermoFisher). Primary antibodies: mouse anti-SeV NP 
(clone M73/2 a kind gift from Alan Portner – directly conjugated with Dylight 594 NHS 
Ester (ThermoFisher)), rabbit Anti-HA-Tag (CST C29F4), mouse Anti-FLAG 9A3 (CST 
8146), rabbit Anti-GFP (ab6556), mouse anti-C (clone P16, 96-6, from Toru Takimoto). 
Secondary antibodies: Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 488 
(Invitrogen), Goat anti-mouse IgG (H+L) Secondary Antibody, Alexa Fluor 647 
(Invitrogen); Goat anti-mouse IgG (H+L) Secondary Antibody, Alexa Fluor 488 
(Invitrogen)  
RNA-FISH  
Custom probe sets were designed against the SeV genome (described in(197)) and 
conjugated to Quasar 570 (3’(-)SeV) and Quasar 670 (5’(-)SeV) dyes (LGC Biosearch). 
For RNA-FISH microscopy, cells were seeded on No. 1.5 glass coverslips (Corning) 
prior to infection. Post infection coverslips were rinsed with PBS then fixed in 3.7% 
formaldehyde (ThermoFisher) for 10 min. Cells were permeabilized in 70% EtOH for 1 h 
at room temperature then washed in wash buffer (2X SSC (ThermoFisher), 10% 
formamide (ThermoFisher) in nuclease free water), and then subjected to hybridization 
with FISH probes. For hybridization, probes were diluted to 2.5nM in hybridization buffer 
(wash buffer + dextran sulfate) and applied to slides. Slides were incubated with probe 
overnight at 37°C in a humidified chamber. Prior to imaging, slides were washed in wash 
buffer twice (once with Hoechst to stain nuclei) then 2X SSC. Cells were mounted in 
ProLong Diamond Antifade Mountant (ThermoFisher) and cured overnight at room 
temperature prior to imaging. RNA FISH combined with immunofluorescence was 
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modified by staining cells with antibody after permeabilization with EtOH. Cells are 
stained with antibody in 1% BSA (ThermoFisher) PBS with RNaseOUT (Invitrogen) for 
45 min for 1° Ab and 40 min for 2° Ab. Cells were then post-fixed for 10 min in 3.7% 
formaldehyde prior to hybridization.  
RNA FISH Flow Cytometry 
Cells were harvested post infection by trypsinization (ThermoFisher) and centrifugation. 
Cell pellets were washed in 1% FBS in PBS one time. Cell pellets were then 
resuspended in 10mL ice cold methanol (ThermoFisher) and fixed and permeabilized on 
ice for 10 minutes before pelleting at 1500rpm for 5 minutes. Pellets were then 
resuspended in 1mL wash buffer per sample and transferred to a microcentrifuge tube 
where they were washed twice. For hybridization probes were diluted to 25nM in 100ul 
hybridization buffer (wash buffer + dextran sulfate) and cell pellets were resuspended in 
hybridization buffers and incubated overnight at 37°C. For antibody staining, primary 
antibodies were added to the hybridization buffer and incubated overnight. Post-
hybridization cell pellets were washed in wash buffer twice, then washed in 2X SSC 
before being resuspended in anti-fade buffer (2X SSC, 0.4% glucose (Sigma), Tris-HCL 
pH 8.0 (USB Corporation) with Catalase (Sigma) and Glucose Oxidase (Sigma)). For 
secondary antibody staining, antibody was added to wash buffer prior to washing with 
2X SSC and incubated at 37°C for 30 minutes. Flow cytometry was performed on a BD 
LSRFortessa and compensation and gating was done in FlowJo_v9.9.4 (BD 
Biosciences). Mock and SeV LD infections were used to inform gating of SeV HD DVG-
high and FL-high populations.  
Microscopy and Image Analysis 
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Images were acquired on a Leica SP5-II Laser Scanning Confocal with 63X (1.40-0.60 
NA) and 100X (1.46 NA) oil-immersion objectives with pixel size 70x70nm for FISH 
immunofluorescence, with z-step size of 0.13um, with 15 slices total. 
Immunofluoresence images (Rab11a colocalization) were acquired with the same 
parameters except for a pixel size of 40x40nm. Images were processed in Volocity 
(Perkins-Elmer) and deconvolution when performed was done with Huygen’s Essential 
Deconvolution Wizard using theoretical point spread function. Colocalization was 
quantified in Volocity with manually defined ROI’s using automatic thresholding based on 
(195).  
Immunoprecipitation  
Cells were lysed in NP-40 lysis buffer (Amresco) with proteinase inhibitors (Roche 
Boehringer Mannheim), RNase OUT (Invitrogen) and EDTA (ThermoFisher). Protein 
concentration was measured using BCA Protein Assay (ThermoFisher). For anti-NP 
immunoprecipitation: 500ug of protein was incubated overnight with primary antibody 
(anti-SeV NP). Protein G Magnetic Beads (EMD Millipore), 30ul per sample, were 
blocked overnight with Salmon Sperm DNA (ThermoFisher) in 5% FBS/PBS. Beads 
were washed and incubated with lysate/antibody for 4 hours at 4°C while rotating. For 
anti-NP immunopreciptations, beads were added 3 times sequentially. Beads were then 
washed with high salt lysis buffer threes times, then low salt lysis buffer once. Samples 
for RNase treatment were stopped here, samples for other applications were boiled in 
sample buffer for 10 minutes. For Rab11-GFP immunoprecipitation: Anti-GFP 
immunoprecipitation was carried out using anti-GFP mAb magnetic beads. 500ug 
lysates were incubated overnight with beads, then washed five times with wash buffer 
(50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.05% NP-40).  
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Sample preparation for proteomic analysis  
All chemicals used for preparation of nanoflow liquid chromatography-tandem mass 
spectrometry (nLC-MS/MS) samples were sequencing grade and purchased from 
Sigma-Aldrich (St. Louis, MO), unless otherwise stated. Immunoprecipitated GFP-
Rab11A interacting proteins (Rab11A IP) were eluted from the magnetic beads by the 
on-beads tryptic digestion. Briefly, the beads were resuspended in 50 µl of 50 mM 
triethylammonium bicarbonate, pH 8.5 (TEAB, Thermo Fisher Scientific, Waltham, MA) 
and proteins were reduced using 10 mM dithiothreitol (DTT) for 1 h at room temperature 
and alkylated with 20 mM iodoacetamide (IAA) in the dark for 30 min at room 
temperature. Proteins were digested with trypsin (Promega, Madison, WI) at an enzyme-
to-substrate ratio of ∼1:50 for 12 h in a thermomixer, shaking at 900 rpm, at room 
temperature. After digestion, the supernatant was removed and collected into fresh, 
labelled tubes. Beads were washed twice with 50 µl of the wash buffer (50 mM TEAB pH 
8.5, 5% acetonitrile) and all supernatants were merged. The samples were concentrated 
to the volume of ∼100 μl by lyophilization and acetified with trifluoroacetic acid (TFA) to 
a final concentration of 0.1%. The tryptic peptides were desalted using Poros Oligo R3 
RP (PerSeptive Biosystems, Framingham, MA) P200 columns with C18 3 M plug (3 M 
Bioanalytical Technologies, St. Paul, MN) prior to nLC–MS/MS analysis.  
The whole cell proteome samples were processed using the suspension trap (S-Trap, 
Protifi, Huntington, NY)(207) mini spin column digestion protocol with minor 
modifications. Briefly, cells were lysed in 300 μl of lysis buffer (5% SDS, 50 mM TEAB 
pH 7.55, Halt™ protease and phosphatase inhibitor cocktail (Thermo Fisher Scientific, 
Waltham, MA)) by vortexing and probe tip sonication at 4 °C. The lysate was clarified by 
centrifugation at 13,000×g for 10 min, at 4 °C. Protein concentration was measured by 
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Bradford protein assay (Thermo Fisher Scientific) and ~300 µg of reduced and alkylated 
proteins was subjected to trypsin digestion following the S-Trap manufacturer’s 
procedure. The peptide solution was pooled, lyophilized, and desalted prior to nLC–
MS/MS.  
Nanoflow Liquid Chromatography Tandem Mass Spectrometry (nLC-MS/MS) 
The peptide mixture was separated using a Dionex Ultimate 3000 high-performance 
liquid chromatography (HPLC) system (Thermo Fisher Scientific) equipped with a two-
column setup, consisting of a reversed-phase trap column (Acclaim PepMap100 C18, 5 
μm, 100 Å, 300 μm i.d. × 5 mm, Thermo Fisher Scientific) and a reversed-phase 
analytical column (30 cm, 75 μm i.d. 360 μm o.d., in-house packed with Pur C18AQ 
3 μm; Dr Maisch). Loading buffer was 0.1% trifluoroacetic acid (Merck Millipore) in water. 
Buffer A was 0.1% formic acid, and Buffer B was 80% acetonitrile + 0.1% formic acid. 
The HPLC was coupled online with an Orbitrap Fusion mass spectrometer (Thermo 
Fisher Scientific, San Jose, CA). The gradient was 135 min from 2% to 36% buffer B at a 
flow rate of 300 nl/min for GFP-Rab11A samples, and 180 min for whole cell proteome 
samples. The MS instrument was controlled by the Xcalibur software (Thermo Fisher 
Scientific). The nanoelectrospray ion source (Thermo Fisher Scientific) was used with a 
spray voltage of 2.2 kV. The ion transfer tube temperature was 275°C. Data acquisition 
was performed in the Orbitrap for precursor ions. MS survey scans were obtained for the 
m/z range of 350-1200 in the Orbitrap with maximum ion injection time of 100 ms, 
automatic gain control target 5 × 105 and a mass resolution of 120,000. MS/MS was 
performed with a TopSpeed duty cycle set to 3 s. Dynamic exclusion was set to 4 sec. 
Charge state enabled was 2-6+. Higher Collisional Dissociation (HCD) was set to 30. 
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MS/MS was acquired in the ion trap using the Rapid scan mode, an automatic gain 
control set to 10,000 and a maximum injection time set to 120 msec. 
Proteins Identification and Quantification  
The raw mass spectrometer files were processed for protein identification using the 
Proteome Discoverer (v2.4, Thermo Fisher Scientific) and the Sequest HT algorithm with 
a peptide mass tolerance of 10 ppm, fragment m/z tolerance of 0.25 Da, and a false 
discovery rate (FDR) of 1% for proteins and peptides. All peak lists were searched 
against the UniProtKB/Swiss-Prot database of Human (January 2020, 20,367 entries) 
and UniprotKB/TrEMBL Sendai Virus (Cantell); February 2020, 8 entries) sequences 
using the parameters as follows: enzyme, trypsin; maximum missed cleavages, 2; fixed 
modification, carbamidomethylation (C); variable modifications, oxidation (M), protein N-
terminus acetylation. Protein quantifications were log2 transformed and normalized using 
the median of the distribution for each sample. Missing values were imputed using a 
distribution of values of 30% width and two standard deviations lower than the average 
of the distribution of valid values. Statistical analyses were performed on three different 
biological replicates. The sample size was chosen to provide enough statistical power to 
apply parametric tests (either homoscedastic or heteroscedastic one-tailed t test, 
depending on the statistical value of the F-test; heteroscedastic if F-test p value<0.05). 
The t test was considered as valuable statistical test because binary comparisons were 
performed, and the number of replicates was limited. No samples were excluded as 
outliers (this applies to all proteomics analyses described in this manuscript). Proteins 
with t test p value smaller than 0.05 were considered as significantly altered between the 
two tested conditions. Data distribution was assumed to be normal, but this was not 
formally tested.  
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Western Blot  
Whole cell lysate (10μg) or immunoprecipitation products were denatured by boiling for 
10 min and run on a 4-12% Gradient Bis-Tris Gel (Bio-Rad) before being transferred to a 
PVDF membrane (Millipore). Membranes were incubated overnight with primary 
antibody in 5% milk. Membranes was incubated secondary antibody for an hour in 5% 
milk and developed using Lumi-light western blot substrate (Roche) to detect HRP.  
Images were acquired using a ChemDoc biomimager (Bio-Rad) and quantified in 
ImageJ. Primary antibodies: rabbit anti-Rab11a (Invitrogen); mouse anti-C (clone p96-6, 
a kind gift from Toru Takimoto), chicken anti-SeV polyclonal.  Secondary antibodies: 
anti-rabbit HRP-conjugated antibody (Cell Signaling), anti-mouse IgG for IP (Abcam), 
anti-chicken HRP-conjugated antibody.  
RNase Treatment  
Post immunoprecipitation unbound fractions or substrate bound to magnetic beads were 
subjected to treatment with a combination of 1U/mL RNase A, V, and T1 (Invitrogen) for 
15 minutes at room temperature. RNase reaction was stopped by adding Trizol LS 
(Invitrogen) to the sample.  
RNA Extraction and RT-qPCR 
Cellular and viral RNA was harvested using Trizol (Invitrogen). RNA was reverse 
transcribed using SuperScript III First Strand Synthesis System (Invitrogen) with OligoDT 
for mRNA specific amplification or with primer 5’-GGTGAGGAATCTATACGTTATAC-3’ 
for viral RNA. qPCR was performed with 1:40 dilution of cDNA, SYBR Green (Life 
Technologies) and 5uM forward/reverse primers (Invitrogen) on an Applied Biosystems 
ViiA 7 Real-Time System. Relative copy numbers per cell were calculated by delta-delta 
Ct and normalized to average cellular GAPDH expression levels. Primer sequences are: 
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SeV NP (F: 5’ TGCCCTGGAAGATGAGTTAG-3’ R: 5’-GCCTGTTGGTTTGTGGTAAG -
3’); SeV P/C (F: 5’- GGATATCCGAGATCAGGTATTGA-3’ R: 5’-
GGCCCGGTGTATATTTTGTTT-3’); SeV M F: (5’- GCCATCCCCTACATCAGGAT-3’ R: 
5’- GTAACGACCCGGAGCCGCAT-3’); SeV F (F: 5’-CTCCTGAAGATCTCTAAGGCAT- 
3’ R: 5’-GGATCCCACGAATCGAGGTA3’); SeV HN F: (5’- 
GACCAGGAAATAAAGAGTGCA-3’ R: 5’-CGATGTATTGGCATATAGCGT-3’); SeV L (F: 
5’- TGGTCAGAGATGCAACGAGA-3’ R: 5’-ACCTTTCAAGGACTGGATGC-3’); gSeV (F: 
5’-GACCAGGAAATAAAGAGTGCA-3’, R: 5’-CGATGTATTGGCATATAGCGT-3’), DVG-
546 (F: 5’-TCCAAGACTATCTTTATCTATGTCC -3’, R: 5’-
GGTGAGGAATCTATACGTTATAC-3’). 
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CHAPTER 4: Conclusions and Future Directions 
99 
 
4.1 Summary of findings 
Defective viral genomes (DVGs) generated during paramyxovirus infections are 
able to alter the outcome of these infections primarily by inducing antiviral immunity and 
interfering with standard viral genome replication. This dissertation sought to address 
how different intracellular localizations of full-length (FL) and defective viral genomes 
during Sendai virus (SeV) infection influenced viral infections and asked what these 
differential localizations could teach us about paramyxovirus particle assembly. Chapter 
2 describes the discrete localizations of SeV DVGs and FL genomes, with genomes in 
FL-high cells engaging with Rab11a marked recycling endosomes, and genomes in 
DVG-high cells failing to engage with the host in this way. We found that these distinct 
interactions contributed to differences in viral particle production with FL-high cells being 
the primary producers of both standard and defective viral particles, and DVG-high cells 
not contributing to the pool of infectious particles produced during infection(197).  In 
Chapter 3, we addressed the viral determinants that drive FL-high cells to interact with 
Rab11a-containing recycling endosomes. We demonstrated that high levels of viral 
polymerase components including L and C, are differentiating factors in cells that 
proceed to viral assembly in contrast to DVG-high cells that solely carry out genomic 
replication. We propose that C and L proteins are critical in mediating viral genome 
engagement with recycling endosomes. Overall, this work has contributed to the 
understanding of how DVGs modulate infection outcomes by focusing on differential 
particle production in cells, as well as uncovered fundamental aspects of paramyxovirus 
assembly. This chapter will discuss broader implications and future directions for these 




4.2 DVG induced heterogeneity  
 The presence of defective particles during infection leads to heterogeneous 
accumulation of viral genomic material in infected cells, with some cells accumulating 
predominantly FL genomes (FL-high cells) and others accumulating predominantly 
DVGs (DVG-high cells). This type of heterogeneity has been observed for SeV(165) and 
described in depth in chapter 2, and has also been observed in influenza (208, 209) and 
respiratory syncytial virus(165) infections. The differences in viral product accumulation 
results in unique transcriptional responses of the infected cell populations and 
corroborates the role of DVGs as strong innate immune agonists. The work presented 
here, expands on impacts of this heterogeneity and indicates that the genomic 
accumulation influences particle production as well(197). Despite new appreciation that 
heterogeneity in DVG accumulation can influence cellular outcomes during infection, 
questions remain, including: What viral or cellular factors contribute to the heterogeneity 
that is observed? What does this heterogeneity look like in tissue or animals? 
4.2.1 Drivers of heterogeneity 
 During SeV infection with high DVG (HD) stocks of virus, we observed 
heterogeneous accumulation of viral genomes amongst infected cells. Though the work 
presented here focused on descriptions of DVG-high and FL-high cells, which each 
comprise approximately 30% of the infected cell population, there are two other 
categories of cells which make up the rest of the population: intermediate cells, which fall 
between the phenotype of DVG-high and FL-high cells based on characterization of 
vRNA FISH probe binding, and cells with non-detectable (ND) levels of viral RNA based 
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on vRNA FISH(165). The factors that impact the distribution of these populations have 
yet to be characterized.  
 We hypothesize that the driving factor for determining a DVG-high or FL-high 
phenotype is the ratio of defective particles to standard virions that infect a particular 
cell. This hypothesis is supported by the ability to manipulate the proportions of DVG-
high and FL-high cells in an infection by the addition of different amounts of purified 
defective particles (pDPs). The addition of increasing amounts of pDPs led to an 
increase in DVG-high cells (Figure 2.2). Interestingly, increasing the amount of pDPs 
past a certain threshold led to an increase in ND cells (Figure 2.1), suggesting that ND 
cells are the product of a single cell receiving an input with a high ratio of DVGs:standard 
genome, rather than due to lack of infection, particularly since infections are performed 
at an MOI 1.5 to ensure that at least 80% of the cells receive an infectious viral particle.  
 While the varying ratios of DPs:standard virions that cells receive is likely the 
driver of heterogeneity in infection, the precise ratios that lead to the development of 
each cell phenotype are not known. Use of new technologies available to more 
accurately measure the number of defective particles added to an infection could help 
define these ratios. Digital droplet PCR (ddPCR), which allows for quantification of RNA 
in the absence of a standard curve, could be used to perform sensitive quantification of 
viral RNA on both viral stocks and on purified DPs. In fact, ddPCR methods have been 
used to perform sensitive quantification of influenza virus(210) and Nipah virus 
DVGs(211), indicating that this would be a suitable method for quantification of DVGs in 
purified particle and virus stocks. With the ability to quantify numbers of DVGs in 
particles, we could perform infections with varying ratios of purified defective particles 
and standard virus and quantify cell populations by RNA FISH coupled with flow 
cytometry. These data sets would allow us to calculate the ratio of DPs:standard virions 
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that lend to the various cell phenotypes by quantifying ratios of cell phenotypes and 
fitting them with Poisson distributions of probability of cells receiving each particle ratio 
during infection.   
 Interestingly, FL-high cells in HD infections harbor DVGs and produce defective 
particles at a higher rate than FL-cells in low DVG (LD) infections (unpublished 
observation). In LD infections, DVGs must be generated de novo during infection and 
DPs are produced at much later timepoints than in HD infections, suggesting that FL-
high cells in HD infections receive defective particles upon infection, but in insufficient 
quantities to lead to the development of a DVG-high cell phenotype. This suggests that a 
ratio greater than 1:1 DPs:standard virion is required to generate a DVG-high cell, in 
contrast to what has been reported for VSV, where even one defective particle was 
sufficient to suppress viral particle production(175). The ratios that lead to a DVG-high 
cell phenotype may vary in different viral infections or even in infections with the same 
standard virus but with different DVG species due to differences in DVG replication 
rates. Differences in DVG size or viral promoters may affect the ratios of DPs:standard 
that lead to different cell phenotypes.  
 We have also questioned whether cellular factors influence the development of 
DVG-high and FL-high cells during infection. The primary factor that may influence 
accumulation of viral products is which stage of the cell cycle cells are in during 
infection. Many DNA and RNA viruses employ diverse strategies to promote certain cell 
cycle stages to enhance their replication(212). For example, the M2/G stages of the cell 
cycle are more permissive to VSV replication(213). Whether cell cycle affects 
accumulation of DVGs or FL genomes can be addressed by synchronizing cells to 
different phases of the cell cycle prior to infection then performing vRNA-FISH flow 
cytometry and quantifying the proportions of DVG-high and FL-high cells generated 
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during infections at each phase of the cell cycle. Similar experiments have been done 
with picornaviruses and have concluded that different cell cycle phases do not affect the 
observed heterogeneity of infection(185). Additionally, given robust evidence that 
varying input of defective particles can alter the number of DVG-high cells, we favor the 
hypothesis that variations in cell cycle would minimally impact ratios of DVG-high and 
FL-high cells.   
4.2.2 Heterogeneity in tissue and animal models 
The accumulation of heterogenous levels of viral genomes during infection has 
primarily been observed in cell culture monolayers with synchronous infections using HD 
stocks of virus. An outstanding question is whether these phenotypes will be 
recapitulated in vivo. Large bottlenecks during natural transmission of infections mean 
that likely very few virions initiate natural infections(144). As discussed in the 
introduction, we hypothesize that during initial infection, a single virion seeds a local 
focus of infection and that progressive rounds of amplification will eventually lead to 
generation of DVGs which will be packaged into DPs. This would create a 
microenvironment in which new cells may be infected by standard and defective 
particles at varying ratios, eventually recapitulating HD infection phenotypes observed in 
vitro. Because SeV is a natural murine pathogen and replicates robustly in the lungs of 
infected mice, the question of whether we see this heterogeneity in vivo can be 
addressed by performing RNA FISH on lung tissues of infected animals at different 
timepoints of infection. Experiments can be performed where mice are infected with SeV 
LD and development and expansion of foci of infection can be observed and assessed 
for the appearance of DVG-high cells. Mice can also be infected with SeV HD and lungs 
can be assayed for the presence of DVG-high cells. Preliminary data from the laboratory 
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shows that upon infection of mice with SeV HD, DVG-high cells are identifiable, but they 
are low in abundance. The primary issue with performing experiments using RNA-FISH 
in vivo has been difficulty in visualizing low levels of signal with high background of 
fluorescence in lung tissue, however new strategies to increase intensity of RNA-FISH 
probe signals including CLAMP-FISH(214), may be useful in visualizing early events of 
viral infection in the lung. Further, techniques to combine RNA-FISH with 
immunostaining developed in Chapter 3 could aid in identifying DVG-high populations in 
the lung.   
The lung is composed of multiple cell types, including type I and type II 
pneumocytes that make up the alveoli, as well as structural cells and immune cells such 
as resident alveolar macrophages and others(215). During infection with SeV, there is 
rapid recruitment of immune cells, predominantly neutrophils followed by T and B cells 
required for infection clearance, all of which are able to be infected by SeV(140, 216, 
217). Whether heterogeneity of genome accumulation as well as differences in 
intracellular distribution of DVGs and genomes, would be observed in different cells 
infected in the lung remains to be investigated. The majority of the data presented here 
is from infections performed in the tissue culture cell line A549 which are type II 
pneumocytes. However, all tissue culture cell lines investigated as well as primary lung 
fibroblasts have shown similar heterogeneity and intracellular distribution to that 
characterized in A549s. Based on these data, we hypothesize that in vivo pneumocytes 
and structural cells would display similar heterogeneity and intracellular distribution as 
described here. However, this may not be the case for immune cells. While we have 
measured high amounts of viral RNA in neutrophils, and plasmacytoid dendritic cells 
(pDCs) are also susceptible to viral infection, these cells are likely not sources of virions. 
Therefore, because intracellular distribution of RNA is directly related to virion 
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production, we would not expect to see these distinct intracellular distributions in these 
cell types. This could be confirmed by using RNA FISH on these cells either in in vivo 
tissue slices or by ex vivo cultures and subsequent infections of these cell types. We do 
know that DVG replication in pDCs is important for initiation and orchestration of immune 
responses(164). Therefore identifying whether different cell types develop DVG-high 
cells and whether these cells are the producers of DPs in vivo is important to better 
understand the initiation of an immune response.  
4.3 Altered Infection Dynamics in the Presence of DVGs  
In Chapter 2, we explored how the presence of DVGs alters which cells are able 
to produce DPs and standard virions and in Chapter 3, we investigated the impact of 
DVGs on interference with viral mRNA expression and viral protein accumulation. 
Overall, a better understanding of the dynamics of DVGs influence on infection can help 
address larger questions of the impact of DVGs during infection, including: Can we 
better model the impact of DVG interference during infection? How can this inform our 
models of pathogenesis at a tissue or animal level? How does this understanding impact 
the development of DVGs as therapeutics or antivirals?  
4.3.1 DVG Impacts on Interference and Pathogenesis 
DVGs have been well documented to exert influence on infection through 
interference with production of viral proteins through a number of mechanisms, as 
illustrated in (Figure 1.4)(92, 218). Competition and viral outgrowth assays in the 
presence of DPs have been extensively studied in vitro using VSV to inform 
mathematical models. Most often, the presence of DPs delayed, but did not shut down, 
viral protein expression in infected cells. Previous models suggested that low levels of 
DPs were sufficient to prevent infection(219), but updated models support a multi-hit 
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hypothesis whereby varying levels of input of DPs lead to divergent outcomes of 
infection: inhibition of total particle production, limited production of standard virus but 
high levels of DPs, and low levels of DPs but high levels of standard virus(220). Yet, 
these parameters may change based on the characteristics of the DVGs or standard 
virus used for these competition assays. Intriguingly, experiments performed using VSV 
found that while small numbers of DPs can completely shut down production of 
infectious virus, high levels of DPs prevented this inhibitory effect(175, 186). Further, 
virus production can be inhibited with a low input of DPs per infectious virus but cannot 
completely eliminate virus production even at very high rates of DPs(174, 221). Gaining 
a better understanding of the interplay between standard virus and DVGs at varying 
ratios could provide insight for the use of DPs as therapeutic particles or for 
understanding how interference modulates pathogenesis in vivo. 
The delay in virus production and viral replication induced by DVGs is 
hypothesized to increase the time over which virus is produced and perhaps extend 
infection(186). Multiple models have been created to help researchers understand how 
the inclusion of DPs during infection impacts viral production, as mentioned above, and 
limits viral spread(221). However, the production of DPs and how it changes during 
infection have not been included in these models, leaving us wondering how these 
important aspects of the virus life cycle impact the dynamics. The data presented in 
Chapter 2 could aid in the inclusion of DPs in models of multicycle infections and better 
represent dynamics of infections in tissues or more complex landscapes. 
Further, in chapter 3 we provide a comprehensive investigation into the effects of 
interference on the accumulation of multiple viral proteins in a comparative manor. We 
show that viral proteins that are least abundant, namely L, are most reduced when 
subjected to DVG-mediated interference. Based on our data of mRNA and genome 
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amounts over time, we can begin to build more informed mathematical models of viral 
replication rates and how the presence of DVGs affect replication and transcription rates. 
We have begun to develop mathematical models that reflect how interference by DVGs 
may affect protein accumulation and thus viral genome replication and virion production. 
Using these models we can vary the amounts of DVGs in the system upon input and ask 
how varying levels of DVGs can affect cell fate via interference with certain proteins. We 
could also include data from proposed experiments from section 4.2.1 on varying levels 
of input DPs, to understand the dynamic range of DPs/DVGs influence on infections. We 
can also expand these models to population based models, and combining the data from 
Chapter 3 on viral proteins critical for viral particle assembly and the data in Chapter 2 
regarding viral particle production during DVG induced heterogeneity, we can begin to 
accurately model population dynamics in the presence of DVGs. Building these models 
will allow us to better understand the role of DVGs during infection and help guide the 
use of therapeutic DVG administration during disease.  
4.3.2 Implications for prophylaxis and persistence  
 Therapeutic administration of DVGs either as a prophylaxis to induce a protective 
immune response or as a therapeutic to attenuate replication of virus has begun to be 
explored(114, 222-224). Results detailed in Chapter 2 indicate that high levels of 
defective particles can generate high percentages of DVG-high cells, and these DVG-
high cells are incapable of generating either defective particles or standard virions. The 
inability of these cells to generate standard virions is protective and would achieve the 
goals of reducing viral loads by the administration of DVGs or pDPs. In addition, our lab 
has demonstrated that DVG-high cells initiate a unique pro-survival transcriptional profile 
as a result of MAVS-induced antiviral signaling. This pro-survival program protects these 
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cells from TNF-mediated cell death(165). While this work has not been expanded to in 
vivo experiments, the concept of cells being protected from cell death and unable to 
produce viral particles, seems like it would indeed bolster recovery from viral infection, 
as lung damage during respiratory infections is driven by death of infected cells(225).  
However, we must also consider the long-appreciated role of DVGs in persistent 
infections. DVGs and DPs from many viruses, including paramyxoviruses, have been 
associated with the establishment of persistent infections in both tissue culture and 
animal models(226). Recently, our lab associated this with the pro-survival pathway 
upregulated by DVG-high cells and posited that these DVG-high cells may survive past 
the acute phase of infection and act as reservoirs for virus which may become activated 
due to immunosuppression or periods of stress later in life(165). Therefore, it is 
important to fully understand the dynamics between DVG-high and FL-high cells and 
reach an appropriate balance of these cells during prophylactic or therapeutic 
administration of DVGs/DPs to maximize disease amelioration and minimize long-term 
consequences.   
4.4 Paramyxovirus Interactions with Recycling Endosomes During Assembly 
 In Chapter 3 we suggest that polymerase components, namely the polymerase L 
and polymerase cofactor C are important in initiating contact between viral genomes or 
viral ribonucleoproteins (vRNPs) and recycling endosomes for the production of 
infectious particles. We also explore the role of the matrix protein (M) in regulating viral 
assembly. However, there are many areas of this research which should be expanded to 
more comprehensively understand the role of polymerase components in paramyxovirus 
assembly, including: What molecular characteristics of C protein allow for interaction 
with recycling endosomes and how is C protein affected by interference? How is M 
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trafficked to the plasma membrane and when does it interact with Rab11a? Which host 
proteins are required for vRNP trafficking and how are host cells impacted by viral 
assembly? Are the mechanisms described here conserved for other paramyxoviruses? 
And what are the implications for these findings in the development of antivirals?  
4.4.1. Further characterization of polymerase components required for assembly 
 Our current model for interactions between vRNPs and Rab11a is that in FL-high 
cells when there is accumulation of polymerase to sufficiently high levels, all vRNPs are 
occupied by multiple copies of the viral polymerase (approximately 40 copies as 
determined by the amount seen on vRNPs recovered from infectious virions)(199, 200). 
C protein is covalently attached to L protein(227), presumably acting as a regulator of 
polarity of genome replication, favoring production of negative strand genomes at this 
time point of infection(31, 73, 119). This C protein is in turn interacting with Rab11a, 
either directly or through one another host protein.  
 Because C proteins are generated from P mRNA, instead of as an independent 
gene product, it is not straightforward to generate a virus which does not generate C 
proteins without disrupting expression of P. There have been multiple independent 
attempts to create a SeV that lacks the four C proteins(72, 228). The SeVΔC virus 
generated by the Kolakofsky lab was generated by altering the C and C’ protein start 
codons(72). We obtained this virus to test for the involvement of C protein in intracellular 
genome localization, however validation in our hands revealed that some version of C 
protein was present as a fusion with P protein, as detectable by western blot and 
immunofluorescence with an anti-SeV C monoclonal antibody. The Nagai group has also 
created a recombinant virus, SeV 4C(-), through the creation of four consecutive stop 
codons after all four C proteins(228). We could infect cells with this virus to directly study 
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the impact of C proteins on the intracellular localization of viral genomes. I hypothesize 
that in the absence of C proteins, viral genomes in FL-high cells will fail to interact with 
Rab11a. Indeed, a profound decrease in peak viral titers is observed when cells or 
embryonated chicken eggs are infected with 4C(-) viruses(31, 70, 228) and C has been 
thus hypothesized to play a role in particle formation(68, 70). If indeed infections with 
4C(-) showed defects in vRNP engagement with recycling endosomes, we could identify 
which C protein family member which may be essential in interacting with Rab11a, and 
further map which regions or residues are essential in this interaction. Paramyxoviruses 
tolerate insertion of additional proteins in their genomes, and indeed additional copies of 
C have been added to the paramyxovirus genome in the presence of C ablation to 
confirm the role of C protein during infection (118). We could create recombinant viruses 
that expressed only one C protein at a time and RNA FISH combined with 
immunofluorescence could be used to assay for interaction between viral RNA and 
Rab11a in the presence of the expression of single C proteins. If a specific C protein is 
been identified, similar experiments could be repeated with the insertion of distinct 
regions of this C protein or C protein with deletions or mutations and assayed similarly to 
identify which regions of C are critical for mediating the interaction with recycling 
endosomes. The residues required for C protein to antagonize innate immunity and to 
regulate genome polarity have been mapped by mutation (229) and the first 98 amino 
acid residues have been deemed dispensable for these functions(230), indicating they 
perhaps serve other functions such as bridging interactions between vRNPs and Rab11. 
 Completing these experiments would further define the interactions of Sendai 
virus and the host via its C protein and confirm the role of polymerase components as 
essential in regulating the interactions between vRNPs and Rab11a during infection.  
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4.4.2 Effects of interference on C proteins  
 While we were able to measure and compare accumulation of viral RNA over 
time in LD and HD infections, we are unable to perform similar measurements for C 
because the protein is generated from the P mRNA. Levels of P mRNA are reduced in 
HD infections compared to LD infections at 12 hours post infection, but not to a 
significantly greater degree than any other viral transcript. We could investigate whether 
there are differences in C proteins in FL-high and DVG-high cells. Preliminary data from 
immunofluorescence microscopy indicates that there is less C proteins in DVG-high cells 
than FL-high cells. We attempted to quantify this using RNA FISH combined with flow 
cytometry, but extremely low levels of C proteins are hard to detect by this method. An 
alternate strategy would be simply to compare the levels of C proteins by flow cytometry 
in SeV LD and SeV HD infections and ask whether levels of C proteins are globally 
reduced to the same extent that L proteins are during infection, or whether they are less 
significantly reduced similar to the effects on NP proteins. Because P mRNA levels are 
not significantly reduced, the levels of C in DVG-high and FL-high cells might be similar. 
We do not understand the factors that induce ribosomal skipping or shunting that result 
in usage of alternative start codons to produce C proteins. However, it may be that these 
fairly rare events cause C levels to be more sensitive to reduced P mRNA levels. 
Understanding how alternately translated proteins are affected by interference may shed 
light on mechanisms that drive alternate translation of mRNAs during viral infection as 
well as add to our understanding of how low abundance proteins are influenced by 
interference.    
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4.4.3 Further characterization of matrix proteins role in viral assembly  
 In Chapter 3, we also characterize the role of the viral matrix protein (M) in SeV 
assembly. We propose a model whereby L and C proteins are essential in driving 
association of vRNPs with Rab11a and that M is trafficked independently and interacts 
with vRNPs at the plasma membrane of infected cells. These conclusions rely on the 
characterization of the intracellular localization of M at 24 hours post infection, a time of 
robust viral particle production. In order to fully characterize the important role that M 
plays during infection and fully elucidate where and how it functions during assembly, we 
could perform a number of experiments. First, more detailed time courses of M 
localization during infection using the already generated recombinant virus would help 
clarify when and how M accumulates at the plasma membrane during infection. 
Immunofluorescence to detect M via HA tag in combination with other viral proteins such 
as C protein could illuminate the sites of their interactions. Additionally, localization of 
SeV F or HN proteins and M could be used to determine whether M interacts with these 
proteins during trafficking through the trans-golgi network (TGN). Though our results 
indicated that SeV M did not have large degrees of colocalization with Rab11a, M is 
identified by mass spectrometry to immunoprecipitate with Rab11a. We have yet to 
investigate whether we see interactions between M and the TGN, which would support 
interactions with cytoplasmic tails of surface proteins during their transit and explain 
some level of interaction between M and Rab11a. Further, while time course studies 
could help detail the dynamics of M during infection, the creation of a recombinant virus 
with a fluorescent protein tag could enhance our ability to study the dynamics of M 
during infection.  M is an oligomeric protein and does not tolerate a tag at the C-terminal 
of the protein and may not tolerate a large tag at the N terminus, but rescue of a virus 
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with a GFP or mCherry protein fused to the N-terminus could be attempted using 
reverse genetics. Infections using a virus with a fluorescent tagged M protein could be 
observed using a spinning-disc confocal over periods of time to observe protein 
movement during infection. These infections could also be observed in fluorescently 
tagged Rab11a cell lines in order to observer real-time interplay between virus and host 
proteins.  
 Additional experiments to confirm the absence of a role for M in the association 
of vRNPs to recycling endosomes could be carried out by creating a virus that lacks M 
protein and observing the intracellular localization of vRNPs during infection with this 
virus. A single-cycle replication competent virus could be generated that lacks the M 
protein in its genome as long as recombinant virus rescue was performed in cells that 
stably expressed M protein. This would allow for the creation of virions which could then 
be used to infect cells but would not be able to express M protein. In the absence of M 
protein, I hypothesize that viral genomes would still interact with Rab11a, confirming the 
absence of a role for M in driving this interaction.  
 Completing these studies would help to understand how matrix functions in 
assembly and define the spatiotemporal aspects of its interaction with host cells.  
4.4.4 Further characterization of host proteins involved in paramyxovirus assembly 
 While it is well-established that viral genomes interact with Rab11a to produce 
new virions(45, 231), it is still not known whether this is a direct interaction between viral 
components and the Rab11a protein itself or whether viral proteins interact with other 
host proteins which in turn interact with Rab11a.It has been suggested that viral 
genomes may interact with Rab11a family interacting proteins (FIPs) which are a family 
of proteins that tether Rab11a to the cell cytoskeleton to direct different types of 
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movement. There are five described FIPs which direct different types of motion within 
the cell (232). In order to investigate whether any of these FIPs are important in bridging 
interactions between vRNPs and Rab11a, we could perform an siRNA screen targeting 
the different FIPs. After knock down by siRNA, cells could be infected with SeV LD and 
immunofluorescence for NP or vRNA FISH for genomes could be applied to determine 
whether perinuclear clustering of viral genomes is disrupted.  If there is an observed 
change in the localization phenotype in any of the knock down conditions, then this could 
indicate that either this FIP is essential for bridging interactions between vRNPs and 
Rab11a or that this FIP is necessary for the movement that directs the clustering of 
Rab11a at the endocytic recycling compartment during viral infection. Different viruses 
have been shown to coopt different FIPs, for example FIP2 has been identified as 
important for the production of respiratory syncytial virus virions (53), while budding of 
filamentous influenza relies on FIP3(52). In order to investigate whether candidate FIPs 
are important for bridging interactions with Rab11a or directing movement of Rab11a, 
we could perform colocalization assays of SeV NP and Rab11a during FIP siRNA 
knockdowns that yielded changes in localization. If we see decreases in colocalization 
between SeV NP and Rab11a during FIP knockdown this indicates that this FIP was 
important in bridging the vRNP-Rab11a interaction. If we do not see changes in 
colocalization but see changes in Rab11a or NP distribution this indicates that this FIP is 
being utilized for Rab11a movement during infection. Performing these experiments 
would help to identify elements of host pathways that are coopted during SeV infection 
and understand how the virus alters host cell dynamics during infection. 
 We have also observed that infection with SeV drastically changes the dynamics 
of the host cytoskeleton and recycling kinetics (unpublished observations). Drastic 
changes in cytoskeleton networks have been observed during infection across many 
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types of viruses including DNA, RNA, and retrovirus infections for entry, replication, and 
assembly(233). We observe large changes in microtubule dynamics during infection with 
SeV LD, decreased transferrin recycling, as well as changes in motor proteins 
associated with Rab11a by mass spectrometry. Preliminary experiments have indicated 
that disruptions to transferrin recycling are blunted in SeV HD infections compared to 
changes seen in SeV LD infections, presumably due to DVG-high cells not disrupting 
normal transferrin recycling rates. Finally, mass spectrometry to identify proteins 
interacting with Rab11a during infection showed large changes in the proteins that 
associate with Rab11a, particularly an increase in proteins that are associated with 
membrane trafficking, indicating that the virus alters the cell in a way that promotes 
particle production. Changes such as these have been identified in other viruses that 
coopt Rab11a pathways during infection, particularly influenza(202, 234). Investigation 
into how these proteins and cellular processes are altered during SeV infection could be 
pursued to get a more complete picture of how SeV alters normal cell physiology during 
infection.  
4.4.5 Assembly mechanisms in other paramyxoviruses  
 While this work has focused on assembly of paramyxoviruses using SeV as a 
model, it could be easily expanded to ask whether the principles uncovered in SeV 
infection are conserved in other viruses. The first virus that ought to be investigated is 
HPIV1 as it is the most closely related human pathogen to SeV. HPIV1 has been 
demonstrated to use Rab11a during viral particle formation(47), and HPIV1 expresses C 
proteins that have 69% protein identity to Sendai virus C proteins,. They also have 
similar described functions in innate immune antagonism (235). Therefore, we could ask 
whether HPIV1 C proteins are involved in regulating engagement of vRNPs with Rab11a 
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using similar approaches as those described in Chapter 3. Similar to experiments 
performed with SeV C proteins, HPIV3 viruses with mutated C proteins have been used 
to map residues that are critical for antagonizing the immune response or regulating viral 
replication(236), therefore it would be reasonable to carry out similar experiments to 
identify residues that are critical for regulating interactions with Rab11a. 
 In addition to the closely related human parainfluenza viruses which are part of 
the respirovirus genus, other paramyxoviruses in the morbillivirus and henipavirus 
genuses also encode C proteins that are multifunctional. The C proteins of measles 
have been well characterized as interferon antagonists(237) and as polymerase 
cofactors that regulate polarity of genome transcription(238, 239). However, the role of 
measles virus C proteins in particle production has yet to be investigated. Likewise, the 
C proteins of NiV have also been described to be polyfunctional, both acting to enhance 
pathogenesis through the antagonism of IFN responses and to participate in enhancing 
particle formation(63, 240). The C protein of NiV has been shown to enhance the 
recruitment of ESCRT proteins to drive budding in the presence of expression of M(63). 
Whether C may also interact with Rab11a in NiV infection is yet to be investigated.    
In contrast, viruses in the rubulavirus genus, such as Mumps, do not express C 
proteins. While mumps uses Rab11a for particle formation, it differs in requirements of 
host proteins during budding, relying on expression of fusion proteins to form VLPs and 
is dependent on ESCRT, unlike respiroviruses(65), indicating that there may be different 
mechanisms of particle productions used by viruses that do not express C proteins. 
Members of the avulavirus genus such as NDV also do not express C proteins. There 
are no reports on whether NDV requires Rab11a for particle formation, but there is 
evidence that VLP formation requires expression of F and HN for homogenous particle 
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formation like for mumps(241), arguing that these viruses have different requirements for 
particle formation than those that express C proteins.  
4.4.6 Implications for development of therapeutics/antivirals  
 Completion of experiments detailed above will help to elucidate the molecular 
mechanisms of paramyxovirus assembly. With a better understanding of how viral 
proteins interact to assemble particles, we can develop virus directed small molecules to 
that prevent the virus from interacting with the host. Identifying residues and regions of C 
proteins in SeV that are critical for regulating these interactions is useful for identifying 
whether there are conserved regions in C proteins that behave similarly across 
paramyxovirus species or genuses. Further, completing more detailed studies of the role 
of M in SeV infection will help to elucidate a previously contested role of this viral protein 
in assembly. A better and more nuanced understanding of this proteins’ role in viral 
assembly will be helpful in the development of antiviral drugs, since, as an oligomeric 
protein, it may be efficiently targeted(242). Additionally, having a better understanding of 
proteins in the host that are manipulated by the virus could give rise to host directed 
therapies that may be more broadly acting than virus directed therapies.  
4.5 Concluding Remarks 
Overall this work provides a better understanding of how DVG induced 
heterogeneity contributes to viral population dynamics. These insights can be used to 
better understand complex interactions between virus, DVG, and the host and model 
viral infections in tissues, as well as inform uses of defective particles as prophylactics or 
therapeutic interventions. Additionally, this work uses DVGs as a tool to expand our 
knowledge on basic paramyxovirus biology and understand critical elements that drive 
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viral genome assembly. The identification of viral polymerase components as critical for 
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